<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.merck.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.merck.com/news-archive/</loc>
		<lastmod>2025-03-12T15:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-construct-new-facility-in-the-united-states-to-expand-manufacturing-capacity-for-tice-bcg/</loc>
		<lastmod>2021-01-27T18:17:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/</loc>
		<lastmod>2021-02-04T16:47:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-outcome-of-oncologic-drugs-advisory-committee-odac-for-keytruda-pembrolizumab-for-treatment-of-patients-with-high-risk-early-stage-triple-negative-breast-cancer-tnbc/</loc>
		<lastmod>2021-02-09T21:30:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-remicade-and-simponi-arbitration/</loc>
		<lastmod>2021-03-08T16:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-investigation-of-pcv-presented-at-advisory-committee-on-immunization-practices-meeting/</loc>
		<lastmod>2021-03-08T16:55:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-voluntary-submission-of-clinical-research-protocols-for-its-investigational-and-approved-products/</loc>
		<lastmod>2021-03-08T16:56:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-gardasil/</loc>
		<lastmod>2021-03-08T16:56:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-the-improve-it-trial/</loc>
		<lastmod>2021-03-08T16:56:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/full-federal-court-rules-in-msd-australias-favour-in-vioxx-case/</loc>
		<lastmod>2021-03-08T16:56:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-information-on-fda-post-marketing-requirement-for-sitagliptin/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-in-new-jersey/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-ariad-pharmaceuticals-provide-update-on-fda-advisory-committee-vote-on-investigational-medicine-ridaforolimus-for-the-treatment-of-metastatic-soft-tissue-or-bone-sarcomas/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-nasonex-mometasone-furoate-monohydrate-patent-trial-in-the-u-s-district-court-for-the-district-of-new-jersey/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-improve-it-trial/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-u-s-regulatory-update-on-investigational-ezetimibe-atorvastatin-tablets/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-suspends-funding-to-the-boy-scouts-of-america/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-continue-work-with-fda-for-oxytrol-as-an-over-the-counter-treatment-for-overactive-bladder-in-women/</loc>
		<lastmod>2021-03-08T16:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-voluntarily-recalls-one-lot-of-gardasil-in-the-united-states/</loc>
		<lastmod>2021-03-08T16:56:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/federal-mdl-court-rules-plaintiffs-failure-to-warn-claim-pre-empted-in-fosamax-alendronate-sodium-bellwether-case/</loc>
		<lastmod>2021-03-08T16:56:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-for-fda-advisory-committee-review-for-investigational-grass-pollen-allergy-immunotherapy-tablet/</loc>
		<lastmod>2021-03-08T16:56:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-combination-medicine-juvisync-sitagliptin-and-simvastatin-tablets/</loc>
		<lastmod>2021-03-08T16:56:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-3/</loc>
		<lastmod>2021-03-08T16:56:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-favorably-resolves-fosamax-alendronate-sodium-onj-litigation/</loc>
		<lastmod>2021-03-08T16:56:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mixed-result-in-federal-trial-involving-fosamax-alendronate-sodium/</loc>
		<lastmod>2021-03-08T16:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-stands-behind-the-safety-profile-of-januvia-sitagliptin/</loc>
		<lastmod>2021-03-08T16:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-2/</loc>
		<lastmod>2021-03-08T16:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mistrial-declared-in-fosamax-alendronate-sodium-new-jersey-state-court-trial/</loc>
		<lastmod>2021-03-08T16:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-u-s-regulatory-update-on-sugammadex-sodium-injection/</loc>
		<lastmod>2021-03-08T16:56:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-4/</loc>
		<lastmod>2021-03-08T16:57:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-stands-behind-the-safety-profile-of-nuvaring-etonogestrel-ethinyl-estradiol-vaginal-ring/</loc>
		<lastmod>2021-03-08T16:57:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-generic-name-for-mk-3475-mercks-investigational-anti-pd-1-antibody-pembrolizumab/</loc>
		<lastmod>2021-03-08T16:57:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-resubmission-of-new-drug-application-for-sugammadex-sodium-injection-2/</loc>
		<lastmod>2021-03-08T16:57:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-voluntarily-recalls-all-lots-of-liptruzet-in-the-united-states-from-wholesalers-due-to-packaging-defects/</loc>
		<lastmod>2021-03-08T16:57:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-increasing-access-to-pediatric-hiv-treatment/</loc>
		<lastmod>2021-03-08T16:57:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-development-program-for-keytruda-pembrolizumab/</loc>
		<lastmod>2021-03-08T16:58:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-sues-merck-kgaa-darmstadt-germany-for-improper-use-of-merck/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-approval-of-2-dose-regimen-of-gardasil-9-for-girls-and-boys-9-through-14-years-of-age/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/sanofi-pasteur-and-merck-confirm-closing-date-to-end-joint-vaccines-operations-in-europe/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-availability-of-zepatier-elbasvir-and-grazoprevir-in-europe/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-filing-plans-for-omarigliptin-an-investigational-dpp-4-inhibitor-for-type-2-diabetes/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-wholly-owned-subsidiary-idenix-pharmaceuticals-inc-awarded-2-54-billion-for-infringement-of-a-hepatitis-c-drug-patent/</loc>
		<lastmod>2021-03-08T16:58:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-in-previously-treated-advanced-microsatellite-instability-high-cancer-2/</loc>
		<lastmod>2021-03-08T16:58:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-top-line-results-from-the-long-term-laba-safety-study-of-dulera-mometasone-furoate-and-formoterol-fumarate-dihydrate-inhalation-aerosol/</loc>
		<lastmod>2021-03-08T16:58:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-vaxelis-merck-and-sanofis-pediatric-hexavalent-combination-vaccine/</loc>
		<lastmod>2021-03-08T16:59:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/varivax-mercks-varicella-chickenpox-vaccine-awarded-who-pre-qualification-status/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-acknowledges-efforts-by-who-acs-and-nci-designated-cancer-centers-to-reduce-the-number-of-men-and-women-affected-by-hpv-related-cancers/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-endorses-the-prevention-access-campaign-undetectableuntransmittable-consensus-statement/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reaffirms-commitment-to-increase-vaccine-production-and-clarifies-rotavirus-vaccine-transition-plan-with-gavi-countries/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-joins-in-recognizing-those-who-responded-to-the-latest-ebola-outbreak/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-continued-commitment-towards-meeting-hpv-vaccine-demand-and-equitable-global-access/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presentations-at-eurogin-2018-show-data-on-hpv-disease-and-vaccination-in-multiple-study-populations/</loc>
		<lastmod>2021-03-08T16:59:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/ervebo-ebola-zaire-vaccine-rvsv%ce%b4g-zebov-gp-live-awarded-prequalification-status-by-the-world-health-organization-who/</loc>
		<lastmod>2021-03-08T17:00:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-remains-steadfast-in-its-commitment-to-supporting-international-response-efforts-to-the-ebola-outbreak-in-the-democratic-republic-of-the-congo-drc/</loc>
		<lastmod>2021-03-08T17:00:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-applauds-adoption-of-universal-health-coverage-declaration/</loc>
		<lastmod>2021-03-08T17:00:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-comment-on-federal-lawsuit-challenging-new-requirements-in-direct-to-consumer-television-advertising/</loc>
		<lastmod>2021-03-08T17:00:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-comment-on-u-s-senate-committee-on-finance-hearing/</loc>
		<lastmod>2021-03-08T17:00:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-remains-committed-to-producing-tice-bcg-for-the-treatment-of-certain-forms-of-bladder-cancer/</loc>
		<lastmod>2021-03-08T17:00:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fdas-oncologic-drugs-advisory-committee-to-discuss-three-indications-for-keytruda-pembrolizumab-during-meetings-focused-on-accelerated-approvals/</loc>
		<lastmod>2021-03-11T21:05:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fdas-oncologic-drugs-advisory-committee-to-discuss-mercks-application-for-keytruda-pembrolizumab-for-the-treatment-of-patients-with-high-risk-early-stage-triple-negative-brea-2/</loc>
		<lastmod>2021-03-17T20:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-sale-of-its-direct-equity-investment-in-moderna/</loc>
		<lastmod>2021-03-17T20:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-unveils-new-website-for-global-study-for-monitoring-antimicrobial-resistance-trends-smart/</loc>
		<lastmod>2021-03-17T20:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-enters-into-voluntary-licensing-agreements-for-doravirine-to-expand-patient-access-in-resource-limited-settings/</loc>
		<lastmod>2021-03-17T20:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-acknowledges-the-end-of-the-ebola-outbreak-in-eastern-democratic-republic-of-the-congo/</loc>
		<lastmod>2021-03-17T20:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-asks-social-media-companies-to-do-as-much-as-they-can-to-stop-hate-speech-racism-and-discrimination-merck-to-stop-advertising-on-facebook-and-instagram-assess-responses-from-facebook-and-moni/</loc>
		<lastmod>2021-03-17T20:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-organon-co-as-new-company-name-for-planned-spinoff/</loc>
		<lastmod>2021-03-17T20:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-renews-commitment-to-gavi-the-vaccine-alliance-as-the-major-manufacturer-of-hpv-vaccines-to-achieve-vaccination-for-84-million-girls/</loc>
		<lastmod>2021-03-17T20:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fdas-oncologic-drugs-advisory-committee-to-discuss-three-indications-for-keytruda-pembrolizumab-during-meetings-focused-on-accelerated-approvals-2/</loc>
		<lastmod>2021-04-29T22:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-confirms-agreement-with-unicef-to-establish-the-worlds-first-global-ebola-vaccine-stockpile-with-ervebo-ebola-zaire-vaccine-live/</loc>
		<lastmod>2021-05-24T18:39:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-clinical-data-for-molnupiravir-generated-by-voluntary-license-partners-in-india/</loc>
		<lastmod>2021-07-09T11:08:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/building-sustainable-value-for-our-business-and-society/</loc>
		<lastmod>2021-09-21T10:45:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-settlement-and-license-agreement-resolving-pneumococcal-conjugate-vaccine-patent-litigation/</loc>
		<lastmod>2021-09-24T14:27:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/gilead-and-merck-announce-temporary-pause-in-enrollment-for-phase-2-study-evaluating-an-oral-weekly-combination-regimen-of-investigational-islatravir-and-investigational-lenacapavir/</loc>
		<lastmod>2021-11-23T21:38:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-ridgeback-statement-on-clinical-trial-of-heteros-generic-molnupiravir/</loc>
		<lastmod>2022-02-19T11:45:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/update-on-our-support-for-ukraine/</loc>
		<lastmod>2022-03-28T10:00:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-commitments-to-pandemic-response-as-part-of-2nd-global-covid-19-summit/</loc>
		<lastmod>2022-05-12T13:00:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lynk-003-trial-evaluating-lynparza-olaparib-with-or-without-bevacizumab-in-patients-with-unresectable-or-metastatic-colorectal-cancer-to-stop-for-futility/</loc>
		<lastmod>2022-07-18T20:00:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-responds-to-sudan-ebolavirus-outbreak-in-uganda-with-plans-to-produce-and-donate-investigational-vaccine-doses-for-iavis-vaccine-development-program/</loc>
		<lastmod>2022-10-25T11:31:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-collaborator-instituto-butantan-announces-results-from-its-phase-3-vaccine-candidate-trial-for-the-prevention-of-dengue-disease/</loc>
		<lastmod>2022-12-16T12:57:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-expenses-related-to-recent-transactions/</loc>
		<lastmod>2023-01-23T11:45:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-sale-of-campus-in-kenilworth-nj-to-onyx-equities-llc/</loc>
		<lastmod>2023-02-16T20:00:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-in-u-s-district-court/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2010-financial-results/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-temodar-patent-infringement-lawsuit-on-appeal/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-partners-make-progress-in-long-term-commitment-to-end-river-blindness/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-another-federal-fosamax-alendronate-sodium-bellwether-trial/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2011-dividend/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-board-elects-kenneth-c-frazier-as-next-ceo-richard-t-clark-to-continue-as-chairman/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-smartcells-inc/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-2-0-billion-debt-offering/</loc>
		<lastmod>2023-03-22T04:04:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/why-so-shy-what-females-of-the-facebook-generation-are-not-sharing-in-the-ob-gyn-office-that-could-affect-their-health/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-appeal-verdict-in-massachusetts-medicaid-case/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2010-sales-and-earnings-conference-call-on-oct-29/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-appeal-reduced-jury-verdict-in-federal-fosamax-alendronate-sodium-case/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lundbeck-and-merck-sign-exclusive-commercialization-agreement-for-sycrest-asenapine-sublingual-tablets-in-all-markets-outside-of-the-united-states-china-and-japan/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/weight-watchers-and-merck-collaborate-to-help-physicians-fight-obesity-through-lifestyle-management-approach/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/tenth-edition-of-the-merck-veterinary-manual-debuts/</loc>
		<lastmod>2023-03-22T04:04:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-non-profit-to-advance-science-education-joins-president-obamas-educate-to-innovate-campaign/</loc>
		<lastmod>2023-03-22T04:04:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-significantly-expands-its-patient-assistance-program-offerings-to-provide-access-to-more-medicines-for-people-in-need/</loc>
		<lastmod>2023-03-22T04:04:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-establishes-new-msd-rd-asia-headquarters/</loc>
		<lastmod>2023-03-22T04:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-for-mothers-and-path-collaborate-to-identify-innovations-that-save-mothers-lives/</loc>
		<lastmod>2023-03-22T04:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-of-zolinza-vorinostat-phase-iii-and-iib-trials-for-investigational-use-for-multiple-myeloma-at-american-society-of-hematology-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-initiation-of-clinical-development-collaboration-with-roche-to-evaluate-investigational-combination-regimens-for-the-treatment-of-chronic-hepatitis-c-genotype-1-infection/</loc>
		<lastmod>2023-03-22T04:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-the-adap-crisis-task-force-announce-new-agreement-to-improve-access-and-care-for-people-with-hiv/</loc>
		<lastmod>2023-03-22T04:04:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2011-financial-results/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-dates-for-rd-and-business-briefing-and-fourth-quarter-2011-sales-and-earnings-report/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-advisory-committee-unanimously-recommends-approval-of-mercks-vytorin-ezetimibe-simvastatin-for-use-in-patients-with-pre-dialysis-chronic-kidney-disease/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-data-for-mercks-victrelistm-boceprevir-in-prior-null-responder-patients-with-chronic-hepatitis-c-genotype-1-to-be-presented-at-the-american-association-for-the-study-of-liver-diseases-2011/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-launches-nexplanon-etonogestrel-implant-68-mg-in-the-united-states-a-long-acting-reversible-hormonal-contraceptive-effective-for-up-to-three-years/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-executing-on-strategy-to-position-company-for-long-term-sustainable-growth/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-pipeline-progress-and-showcases-novel-innovations-at-rd-and-business-briefing/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-2011-credit-suisse-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-partners-make-progress-in-long-term-commitment-to-end-river-blindness-2/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-from-tracer-study-of-vorapaxar-mercks-investigational-medicine-for-cardiovascular-disease-presented-at-aha-and-published-in-nejm/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-resolves-previously-disclosed-seven-year-investigation-led-by-u-s-attorneys-office-for-the-district-of-massachusetts-related-to-vioxx/</loc>
		<lastmod>2023-03-22T04:04:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-new-drug-application-filing-for-ridaforolimus-investigational-mtor-inhibitor/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-retirement-of-chairman-and-former-ceo-richard-t-clark/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-juvisync-sitagliptin-and-simvastatin-tablets-a-once-daily-therapy-for-patients-with-type-2-diabetes-who-need-to-lower-blood-sugar-and-cholesterol-known-risk-f/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-isentress-raltegravir-in-combination-therapy-demonstrated-virological-and-immunological-efficacy-versus-the-efavirenz-regimen-at-192-weeks-of-treatment-in-previously-untreated/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-phase-iib-data-for-mercks-victrelis-boceprevir-in-patients-coinfected-with-chronic-hepatitis-c-and-hiv-1-presented-at-the-infectious-diseases-society-of-america-idsa-2011-annual/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-phase-iii-investigational-studies-evaluating-dulera-mometasone-furoate-and-formoterol-fumarate-dihydrate-inhalation-aerosol-in-chronic-obstructive-pulmonary-dis/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/cdc-advisory-committee-on-immunization-practices-votes-for-expanded-use-of-gardasil-in-boys-and-young-men/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-england-journal-of-medicine-publishes-additional-efficacy-and-safety-data-for-gardasil-in-males/</loc>
		<lastmod>2023-03-22T04:04:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/texas-supreme-court-finds-for-merck-in-vioxx-case/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-morgan-stanley-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-bgi-establish-strategic-collaboration-focused-on-biomarkers-and-genomic-technologies/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-partners-with-susan-g-komen-for-the-cure-on-historic-initiative-to-help-address-cervical-and-breast-cancer-in-developing-nations/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-bank-of-america-merrill-lynch-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-isentress-raltegravir-in-combination-therapy-demonstrated-efficacy-and-tolerability-in-an-observational-trial-in-a-diverse-population-of-adults-with-hiv-1-regardless-of-gender/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-on-odanacatib-mercks-phase-iii-investigational-cat-k-inhibitor-for-osteoporosis-presented-at-the-annual-meeting-of-the-american-society-for-bone-and-mineral-research/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-joins-global-fight-to-help-save-womens-lives-during-pregnancy-and-childbirth/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/study-of-zolinza-vorinostat-for-investigational-use-for-advanced-malignant-pleural-mesothelioma-did-not-meet-primary-endpoint/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-names-cuong-viet-do-as-chief-strategy-officer/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-sells-its-interest-in-johnson-johnson-merck-consumer-pharmaceuticals/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2011-sales-and-earnings-conference-call-on-october-28/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-2010-global-corporate-responsibility-report/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-data-analyses-for-victrelis-boceprevir-will-be-presented-at-the-american-association-for-the-study-of-liver-diseases-2011-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-another-federal-bellwether-trial-regarding-fosamax-alendronate-sodium/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-adds-new-medication-adherence-resources-to-consumer-web-site/</loc>
		<lastmod>2023-03-22T04:04:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2011-sales-and-earnings-conference-call-on-july-29/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-roche-expand-agreement-in-fight-against-chronic-hepatitis-c/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-simcere-sign-agreement-to-establish-pioneering-china-joint-venture/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/rb-legend-natalie-cole-joins-rock-legend-gregg-allman-merck-and-the-american-liver-foundation-to-turn-up-the-volume-around-hep-c/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2011-dividend/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/latest-merck-manual-delivers-trusted-health-care-information-in-print-and-electronic-formats/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-hepatitis-c-community/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2011-financial-results/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-appoints-richard-r-deluca-jr-as-president-merck-animal-health/</loc>
		<lastmod>2023-03-22T04:04:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-deutsche-bank-36th-annual-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-hope-against-hepatitis-c-initiative-to-support-public-awareness-education-and-research-in-the-fight-against-hepatitis-c-virus/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-successful-completion-of-tender-offer-for-shares-of-inspire-pharmaceuticals-inc-with-over-75-percent-of-shares-tendered/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-completes-acquisition-of-inspire-pharmaceuticals-inc/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-roche-establish-strategic-agreements-in-fight-against-chronic-hepatitis-c/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2011-dividend/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-sanford-bernstein-27th-strategic-decisions-conference/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-signs-on-to-united-nations-ceo-water-mandate/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-commends-gavi-alliance-on-continued-efforts-to-improve-access/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/roche-and-merck-collaborate-to-develop-diagnostic-tests-for-mercks-investigational-cancer-therapies/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-goldman-sachs-32nd-annual-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/actress-joanna-garcia-swisher-goes-there-in-a-new-campaign-with-merck-to-motivate-women-to-get-real-when-talking-to-their-physicians-about-their-health/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/legendary-musician-gregg-allman-joins-merck-and-american-liver-foundation-to-launch-tune-in-to-hep-c-public-awareness-campaign/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/ups-and-merck-expand-their-distribution-and-logistics-agreement/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-name-for-its-animal-health-division/</loc>
		<lastmod>2023-03-22T04:04:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-barclays-capital-2011-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2011-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency-epa/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-sanofi-aventis-to-maintain-separate-businesses-in-animal-health/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/jury-finds-for-merck-and-other-defendants-on-the-key-issue-in-an-environmental-contamination-lawsuit/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2011-sales-and-earnings-conference-call-on-april-29/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-inspire-pharmaceuticals-inc/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-co-inc-and-sun-pharma-establish-joint-venture-to-develop-and-commercialize-novel-formulations-and-combinations-of-medicines-in-emerging-markets/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-johnson-johnson-reach-agreement-on-distribution-rights-for-remicade-and-simponi/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reaffirms-2011-non-gaap-eps-target/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-commences-tender-offer-for-all-outstanding-shares-of-inspire-pharmaceuticals-inc/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-5-billion-share-repurchase-program/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-inspire-announce-expiration-of-hart-scott-rodino-act-waiting-period-relating-to-tender-offer-for-shares-of-inspire/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2011-financial-results/</loc>
		<lastmod>2023-03-22T04:04:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-parexel-form-strategic-alliance-focused-on-clinical-development-of-biosimilar-candidates/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-in-new-jersey-state-court/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/john-j-horan-former-merck-chairman-and-ceo-dies-of-natural-causes-at-90-years-of-age/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2010-financial-results/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-first-fosamax-alendronate-sodium-state-court-trial/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2011-dividend/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fujifilm-to-acquire-merck-biomanufacturing-network/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-citi-2011-global-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-cowen-and-companys-31st-annual-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/sisterlove-inc-and-merck-launch-everyone-has-a-story-series/</loc>
		<lastmod>2023-03-22T04:04:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-fourth-quarter-2010-sales-and-earnings-conference-call-on-feb-3/</loc>
		<lastmod>2023-03-22T04:04:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-29th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-new-drug-application-for-suvorexant-an-investigational-insomnia-medicine/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-phase-ii-data-of-mercks-investigational-mk-5172-in-combination-therapy-in-chronic-hepatitis-c-virus-genotype-1-infection-to-be-presented-at-the-american-association-for-the-study-of-liver-dis/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-regenstrief-institute-establish-evidence-based-care-collaboration/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-announce-acceptance-for-review-of-european-marketing-authorization-applications-for-vintafolide-and-companion-diagnostic-etarfolatide-for-folate-receptor-positive-platinum-resistant/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-early-stage-interim-data-for-mk-3475-an-investigational-therapy-for-the-treatment-of-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reports-new-phase-iii-analyses-on-anemia-management-strategies-used-with-victrelis-boceprevir-combination-therapy-including-cirrhotic-patients/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mondo-guerra-of-project-runway-all-stars-unveils-one-of-a-kind-clothing-design-in-honor-of-world-aids-day/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-initiates-phase-ii-iii-study-of-investigational-bace-inhibitor-mk-8931-for-treatment-of-alzheimers-disease/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/the-jama-network-and-merck-announce-strategic-collaboration/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-increases-quarterly-dividend/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-hps2-thrive-study-of-tredaptive-extended-release-niacin-laropiprant-did-not-achieve-primary-endpoint/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-ge-healthcare-collaborate-on-use-of-imaging-biomarkers-for-investigational-bace-inhibitor-clinical-development-program/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-ge-healthcare-collaborate-on-use-of-imaging-biomarkers-for-investigational-bace-inhibitor-clinical-development-program/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-hps2-thrive-study-of-tredaptive-extended-release-niacin-laropiprant-did-not-achieve-primary-endpoint/</loc>
		<lastmod>2023-03-22T04:04:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-continued-commitment-to-global-responsibility/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-ubs-global-life-sciences-conference/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2012-sales-and-earnings-conference-call-on-october-26/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-for-victrelis-boceprevir-and-mk-5172-at-the-american-association-for-the-study-of-liver-diseases-2012-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/phase-iib-data-showed-mercks-investigational-once-weekly-dpp-4-inhibitor-mk-3102-significantly-lowered-blood-sugar-in-patients-with-type-2-diabetes/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-move-global-headquarters-within-new-jersey/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/on-world-sight-day-merck-and-partners-mark-25-years-of-successful-collaboration-to-help-eliminate-river-blindness/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-researchers-present-bmd-data-from-a-phase-ii-study-of-odanacatib-mercks-investigational-cat-k-inhibitor-for-post-menopausal-osteoporosis/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/aicuris-and-merck-enter-exclusive-worldwide-license-agreement-for-investigational-portfolio-targeting-human-cytomegalovirus/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/victrelis-boceprevir-awarded-2012-prix-galien-usa-best-pharmaceutical-agent/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-new-phase-iii-study-amongst-women-for-corifollitropin-alfa-an-investigational-fertility-treatment-for-controlled-ovarian-stimulation/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2012-financial-results/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-resolves-previously-disclosed-missouri-consumer-class-action-lawsuit-related-to-vioxx/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-will-initiate-interferon-free-phase-ii-clinical-trials-for-mk-5172-an-investigational-once-daily-oral-treatment-for-chronic-hepatitis-c-virus/</loc>
		<lastmod>2023-03-22T04:04:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-company-foundation-announces-hiv-care-collaborative-with-atlanta-houston-and-philadelphia-health-departments/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/isentress-raltegravir-in-combination-therapy-demonstrated-long-term-efficacy-safety-and-tolerability-in-previously-untreated-adult-patients-with-hiv-1-for-up-to-240-weeks/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-signs-two-deals-for-novel-hiv-drug-candidates-and-initiates-phase-ii-clinical-trial-of-mk-1439-for-hiv/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2012-dividend/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-collaborators-publish-study-showing-potential-for-eradication-of-persistent-hiv-virus-in-the-body/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-recognizes-world-hepatitis-day-with-partnerships-and-grants-to-support-global-and-u-s-hepatitis-c-communities/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2012-financial-results/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-cardiovascular-development-programs/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/republic-of-uganda-and-merck-launch-cervical-cancer-vaccination-program/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-morgan-stanley-global-healthcare-conference-2/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-phase-iii-data-for-suvorexant-an-investigational-insomnia-medicine/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-2-5-billion-debt-offering/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-developing-medicines-targeting-infectious-disease-at-52nd-annual-icaac/</loc>
		<lastmod>2023-03-22T04:04:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-new-labeling-for-isentress-raltegravir-to-include-156-week-data-demonstrating-long-term-efficacy-safety-and-tolerability-with-isentress-in-combination-therapy-in-previously-untre/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2012-dividend/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/government-of-rwanda-introduces-mercks-rotateq-rotavirus-vaccine-live-oral-pentavalent-to-help-protect-children-against-rotavirus/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-sanford-c-bernstein-28th-strategic-decisions-conference/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-jefferies-2012-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-complete-response-letter-from-u-s-food-and-drug-administration-for-investigational-medicine-ridaforolimus/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-phase-iii-data-showed-mercks-investigational-insomnia-medicine-suvorexant-improved-patients-ability-to-fall-asleep-and-stay-asleep/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-partnership-with-u-s-and-norwegian-governments-and-the-private-sector-formed-to-save-the-lives-of-mothers-and-their-newborn-children/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/u-s-district-court-rules-against-merck-in-nasonex-mometasone-furoate-monohydrate-patent-lawsuit/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-wells-fargo-securities-research-and-economics-2012-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/geisinger-and-merck-to-collaborate-on-multi-year-effort-to-improve-patient-adherence-engagement-and-care-delivery/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-cdc-advisory-committee-on-immunization-practices-recommendation-for-pneumococcal-vaccination-in-immunocompromised-adults/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-astrazeneca-agree-to-amend-partnership/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2012-sales-and-earnings-conference-call-on-july-27/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-collaboration-to-improve-maternal-health-through-expanded-access-to-family-planning/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/update-on-phase-iii-trial-for-odanacatib-mercks-investigational-cat-k-inhibitor-for-osteoporosis/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-data-presentations-at-the-alzheimers-association-international-conference-2012/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-launches-richard-t-clark-fellowship-program-with-psi-partnership/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fashion-designer-and-project-runway-all-stars-winner-mondo-guerra-collaborates-with-merck-to-help-empower-people-with-hiv-to-work-with-their-doctors-to-tailor-their-treatment-plan/</loc>
		<lastmod>2023-03-22T04:04:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-analyses-for-victrelis-boceprevir-will-be-presented-at-the-international-liver-congress-2012-easl-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-enter-exclusive-worldwide-agreement-to-develop-and-commercialize-phase-iii-cancer-candidate-vintafolide-ec145/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-another-fosamax-alendronate-sodium-state-court-trial/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reports-phase-iii-study-results-evaluating-anemia-management-strategies-used-with-victrelis-boceprevir-combination-therapy/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-resolve-remind-couples-that-a-conversation-with-a-specialist-could-be-the-start-of-something-small/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-named-as-leader-in-maplecroft-climate-innovation-index/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/opportunitys-knocking-are-young-adult-women-prepared/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2012-financial-results/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-results-of-a-phase-i-clinical-trial-evaluating-investigational-bace-inhibitor-mk-8931-at-american-academy-of-neurology/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-u-s-zetia-ezetimibe-vytorin-ezetimibe-simvastatin-patent-infringement-lawsuit/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/coppertone-launches-nationwide-contest-in-search-of-modern-little-miss-coppertone/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-deutsche-bank-37th-annual-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/dr-scholls-survey-reveals-america-is-on-the-move-when-foot-pain-doesnt-get-in-the-way/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-bank-of-america-merrill-lynch-2012-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-establishes-joint-venture-with-supera-farma-to-commercialize-innovative-pharmaceutical-products-and-branded-generics-in-brazil/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/singer-jon-secada-joins-merck-and-american-liver-foundations-tune-in-to-hep-c-public-awareness-campaign/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-2012-citi-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2012-dividend/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-cowen-company-32nd-annual-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2012-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency-epa/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-allergy-immunotherapy-tablet-ait-significantly-reduced-the-combination-of-ragweed-allergy-symptoms-and-medication-use-in-phase-iii-trial/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-confirms-2012-full-year-guidance/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-investigational-studies-with-victrelis-boceprevir-presented-at-the-conference-on-retroviruses-and-opportunistic-infections-to-understand-potential-use-in-patients-coinfected-wi/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-barclays-capital-2012-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-partners-with-academic-scientists-and-biotechnology-entrepreneurs-to-create-the-california-institute-for-biomedical-research-calibr/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-safe-water-network-launch-initiative-to-improve-water-access-and-help-reduce-the-impact-of-water-borne-disease-in-india/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/in-tra-2p-study-adding-mercks-vorapaxar-to-standard-of-care-significantly-reduced-the-risk-of-cardiovascular-events/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2012-sales-and-earnings-conference-call-on-april-27/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-appoints-michael-j-holston-as-chief-ethics-and-compliance-officer/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/efficacy-and-safety-data-for-zostavax-zoster-vaccine-live-mercks-shingles-vaccine-in-adults-ages-50-to-59-published-in-clinical-infectious-diseases/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/randy-jackson-partners-with-merck-to-urge-people-with-type-2-diabetes-to-take-their-diabetes-to-heart/</loc>
		<lastmod>2023-03-22T04:04:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/reminder-merck-to-hold-2011-full-year-and-fourth-quarter-sales-and-earnings-conference-call-on-february-2/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-full-year-and-fourth-quarter-2011-financial-results/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-janumet-xr-sitagliptin-and-metformin-hcl-extended-release-for-type-2-diabetes-offering-the-powerful-efficacy-of-janumet-sitagliptin-metformin-hcl-now-available-with-once/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-development-program-for-suvorexant-an-investigational-orexin-receptor-antagonist-for-the-treatment-of-insomnia/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/the-names-project-foundation-and-merck-launch-call-my-name-national-tour-aids-panel-making-workshop-to-focus-attention-on-hiv-aids-crisis-in-african-american-communities/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-top-line-results-of-tra-2p-study-of-vorapaxar/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-informs-u-s-physicians-of-results-of-drug-interaction-study-of-co-administration-of-victrelis-with-ritonavir-boosted-hiv-protease-inhibitors/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/thomas-e-shenk-to-retire-from-mercks-board-of-directors/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/kentucky-court-of-appeals-reverses-certification-of-a-class-of-plaintiffs-seeking-reimbursement-for-vioxx-costs/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-zioptan-tafluprost-ophthalmic-solution-mercks-once-daily-preservative-free-ophthalmic-medication/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-leerink-swann-2012-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-goldman-sachs-2012-healthcare-event/</loc>
		<lastmod>2023-03-22T04:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-isentress-raltegravir-for-use-in-children-ages-two-years-and-older-as-part-of-hiv-1-combination-therapy/</loc>
		<lastmod>2023-03-22T04:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-30th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-resolves-vioxx-litigation-in-canada/</loc>
		<lastmod>2023-03-22T04:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-fda-approved-labeling-for-vytorin-ezetimibe-simvastatin-includes-results-from-the-study-of-heart-and-renal-protection-sharp-in-patients-with-moderate-to-severe-chronic-kidney-disease/</loc>
		<lastmod>2023-03-22T04:04:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-advances-development-program-for-investigational-alzheimers-disease-therapy-mk-8931/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-receives-positive-opinion-from-european-medicines-agency-for-bravecto-fluralaner/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-launch-of-a-new-business-focused-on-comprehensive-evidence-based-weight-management-interventions-in-the-u-s/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-collaborates-with-glaxosmithkline-to-evaluate-novel-combination-regimen-for-advanced-renal-cell-carcinoma/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-for-grastek-timothy-grass-pollen-allergen-extract-mercks-investigational-sublingual-allergy-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-for-grastek-timothy-grass-pollen-allergen-extract-mercks-investigational-sublingual-allergy-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-receives-positive-opinion-from-european-medicines-agency-for-bravecto-fluralaner/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-collaborates-with-glaxosmithkline-to-evaluate-novel-combination-regimen-for-advanced-renal-cell-carcinoma/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-launch-of-a-new-business-focused-on-comprehensive-evidence-based-weight-management-interventions-in-the-u-s/</loc>
		<lastmod>2023-03-22T04:04:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2013-financial-results/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-interim-data-from-phase-1b-study-of-mk-3475-investigational-anti-pd-1-immunotherapy-in-previously-treated-patients-with-non-small-cell-lung-cancer-nsclc-at-15th-wor/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-interim-data-from-study-of-investigational-combination-of-hcv-therapies-mk-5172-and-mk-8742-at-the-2013-american-association-for-the-study-of-liver-diseases-aasld-ann/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-9-valent-hpv-vaccine-v503-prevented-97-percent-of-cervical-vaginal-and-vulvar-pre-cancers-caused-by-five-additional-hpv-types-in-phase-iii-study/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-grass-sublingual-allergy-immunotherapy-tablet-significantly-reduced-allergy-symptoms-and-need-for-symptom-relief-medication-in-adults-and-children-in-pivotal-phase-iii/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-credit-suisse-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-launches-global-awareness-campaign/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-data-to-be-presented-for-mk-3475-mercks-investigational-anti-pd-1-immunotherapy-in-patients-with-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-new-drug-application-for-an-investigational-intravenous-iv-formulation-of-noxafil-posaconazole-receives-fda-priority-review/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/additional-interim-data-for-mercks-investigational-anti-pd-1-immunotherapy-mk-3475-shows-estimated-overall-survival-rate-of-81-percent-at-one-year-in-patients-with-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-data-for-mercks-mk-3475-an-investigational-anti-pd-1-immunotherapy-in-previously-treated-patients-with-non-small-cell-lung-cancer-to-be-presented-at-15th-world-conference-on-lung-ca/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-a-new-poll-many-adults-aged-60-plus-plan-to-take-steps-to-avoid-flu-but-not-other-potentially-preventable-diseases-such-as-shingles/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-of-phase-ii-precedent-trial-for-investigational-folate-receptor-therapy-vintafolide-in-patients-with-platinum-resistant-ovarian-cancer-published-in-journal-of-clinical-oncology/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-new-pharmacokinetic-data-on-isentress-raltegravir-at-14th-european-aids-conference/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-breakthrough-therapy-designation-for-mk-5172-mk-8742-an-investigational-oral-combination-regimen-for-the-treatment-of-chronic-hepatitis-c-virus-hcv-infection/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/zostavax-zoster-vaccine-live-awarded-prix-galien-usa-2013-best-biotechnology-product/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/the-merck-manual-go-to-home-guide-for-symptoms-helps-patients-assess-when-to-worry-and-when-to-wait-determine-next-steps/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-investigational-9-valent-hpv-vaccine-v503-to-u-s-advisory-committee-on-immunization-practices/</loc>
		<lastmod>2023-03-22T04:04:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-durham-site-receives-u-s-fda-licensure-for-varicella-bulk/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-israels-maccabi-healthcare-to-leverage-unique-real-world-database-to-inform-novel-health-approaches/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-new-drug-application-for-investigational-fertility-treatment/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-morgan-stanley-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-astrazeneca-enter-license-agreement-for-investigational-oral-wee1-kinase-inhibitor-therapy-for-cancer/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-named-to-2013-working-mother-100-best-companies/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-complete-response-letter-for-investigational-medicine-sugammadex-sodium-injection/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/oxytrol-for-women-the-first-over-the-counter-treatment-for-overactive-bladder-in-women-now-available-nationwide/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2013-sales-and-earnings-conference-call-on-october-28/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-proudly-supports-vaccination-programs-targeted-at-reducing-disease-in-domestic-pets/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-healths-homeagain-announces-finalists-for-hero-of-the-year-award-voting-begins/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-global-initiative-to-sharpen-commercial-and-rd-focus/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-updates-plans-for-headquarters-move-in-new-jersey/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-from-mercks-investigational-hepatitis-c-treatment-portfolio-to-be-presented-at-the-64th-american-association-for-the-study-of-liver-diseases-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-new-drug-application-for-vorapaxar-investigational-anti-thrombotic-medicine/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2013-dividend/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-regarding-chmp-review-of-incretin-based-therapies-for-type-2-diabetes-including-sitagliptin/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-applauds-colombia-for-first-paho-who-verification-of-elimination-of-river-blindness/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reaffirms-commitment-to-state-aids-drug-assistance-programs-adaps-through-2014/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2013-financial-results/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-2012-global-corporate-responsibility-report/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-her-campus-ask-college-aged-women-to-take-the-pledge-to-plan-it-forward-for-their-futures-by-evaluating-how-todays-decisions-can-affect-tomorrow/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-strengthens-commitment-to-five-steps-to-responsible-beef/</loc>
		<lastmod>2023-03-22T04:04:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-interim-data-from-study-evaluating-lambrolizumab-an-investigational-anti-pd-1-antibody-in-patients-with-advanced-melanoma-at-asco-2013/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/homeagain-launches-program-to-recognize-companion-animal-heroes/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-welcomes-independent-review-of-the-safety-profile-of-januvia-sitagliptin-and-other-diabetes-medicines/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-releases-second-module-in-dairy-care365tm-training-series-milk-parlor-handling/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2013-sales-and-earnings-conference-call-on-july-30/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-complete-response-letter-for-suvorexant-mercks-investigational-medicine-for-insomnia/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-new-u-s-labeling-for-isentress-raltegravir-to-include-240-week-results-from-startmrk-study-of-isentress-containing-regimen-in-previously-untreated-hiv-1-infected-adult-patients/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-findings-from-phase-1b-study-of-investigational-bace-inhibitor-mk-8931-in-patients-with-alzheimers-disease/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-about-sugammadex-sodium-injection/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/best-practices-performance-technologies-presented-at-adsa-asas-joint-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-for-mothers-launches-initiative-in-india-to-reduce-the-number-of-women-dying-during-pregnancy-and-childbirth/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-6-5-billion-debt-offering/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/global-health-development-and-business-leaders-announce-new-innovative-financing-partnership-to-deliver-essential-health-supplies-more-quickly-and-efficiently/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-ubs-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-5-billion-accelerated-share-repurchase/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-for-suvorexant/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-phase-iii-clinical-program-for-preladenant-the-companys-investigational-parkinsons-disease-medicine/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2013-dividend/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-sanford-c-bernstein-strategic-decisions-conference/</loc>
		<lastmod>2023-03-22T04:04:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2013-financial-results/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/dr-mike-apley-recognized-by-peers-for-outstanding-industry-support/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-liptruzet-ezetimibe-and-atorvastatin-a-new-product-that-can-help-powerfully-lower-ldl-cholesterol/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-consumer-care-launches-health-and-wellness-effort-to-help-empower-moms-to-live-a-more-active-lifestyle-with-their-families/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-celebrity-chef-art-smith-cook-up-a-recipe-for-better-type-2-diabetes-management/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-biologics-license-application-for-investigational-ragweed-pollen-sublingual-allergy-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/gardasil-human-papillomavirus-quadrivalent-types-6-11-16-and-18-vaccine-recombinant-mercks-hpv-vaccine-available-to-developing-countries-through-unicef-tender/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-bank-of-america-merrill-lynch-2013-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/cattle-production-veterinarian-hall-of-fame-nominees-announced/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/homeagain-pet-recovery-service-awarded-exclusive-petfindertm-seal-of-approval/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-enters-agreement-with-bristol-myers-squibb-to-conduct-a-phase-ii-clinical-trial-evaluating-combination-of-investigational-oral-candidates-mk-5172-and-daclatasvir-for-chronic-hepatitis-c/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-updated-interim-data-from-phase-ii-trial-evaluating-investigational-ns3-4a-protease-inhibitor-mk-5172-for-chronic-hepatitis-c-virus-genotype-1-infection-at-the-international-liver-con/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-breakthrough-therapy-designation-for-lambrolizumab-an-investigational-antibody-therapy-for-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-named-a-top-50-company-for-diversity-by-diversityinc/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-co-inc-and-pfizer-enter-worldwide-collaboration-agreement-to-develop-and-commercialize-ertugliflozin-an-investigational-medicine-for-type-2-diabetes/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-announces-vetsulin-now-available-to-the-u-s-veterinary-market/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-wins-fosamax-alendronate-sodium-federal-bellwether-trial-involving-atypical-femur-fracture-claims/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-introduces-fresh-new-look-for-safe-guard-equi-bits-package/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-15-billion-share-repurchase-program/</loc>
		<lastmod>2023-03-22T04:04:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-33rd-annual-cowen-health-care-conference/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2013-energy-star-sustained-excellence-award/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-appointment-of-roger-m-perlmutter-m-d-ph-d-as-president-of-merck-research-laboratories-peter-s-kim-ph-d-to-retire/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-hps2-thrive-study-of-tredaptive-extended-release-niacin-laropiprant-presented-at-american-college-of-cardiology-scientific-sessions/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/statement-on-fosamax-alendronate-sodium-product-liability-trial-5/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-improve-it-trial-2/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-luminex-corporation-enter-agreement-to-develop-companion-diagnostic-to-support-investigational-bace-inhibitor-clinical-development-program-for-alzheimers-disease/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-biologics-license-application-for-investigational-grass-pollen-allergy-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2013-sales-and-earnings-conference-call-on-may-1/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/todd-bilby-ph-d-joins-merck-animal-healths-dairy-technical-services-team/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-on-victrelis-boceprevir-and-investigational-compounds-mk-5172-and-vaniprevir-for-chronic-hepatitis-c-virus-at-the-international-liver-congresstm-2013-easl-annual-me/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-new-drug-application-for-an-investigational-tablet-formulation-of-the-antifungal-noxafil-posaconazole/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-opens-new-manufacturing-facility-in-hangzhou-china/</loc>
		<lastmod>2023-03-22T04:04:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-venezuelan-currency-devaluation/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-citi-2013-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2013-dividend/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/bruce-kuhlik-and-merck-honored-by-pbi-for-commitment-to-pro-bono/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-resolves-securities-class-action-lawsuits-related-to-the-enhance-trial/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-samsung-bioepis-enter-biosimilars-development-and-commercialization-agreement/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-analyses-of-its-investigational-ragweed-pollen-and-grass-pollen-allergy-immunotherapy-tablets/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-citi-2013-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2013-dividend/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/bruce-kuhlik-and-merck-honored-by-pbi-for-commitment-to-pro-bono/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-scientist-daria-hazuda-presents-bernard-fields-lecture-at-20th-conference-on-retroviruses-and-opportunistic-infections-croi/</loc>
		<lastmod>2023-03-22T04:04:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2012-sales-and-earnings-conference-call/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-2013-goldman-sachs-healthcare-ceos-unscripted-a-view-from-the-top/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acknowledgement-of-resubmission-of-new-drug-application-for-ezetimibe-atorvastatin-tablets/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-31st-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-resubmission-of-new-drug-application-for-sugammadex-sodium-injection/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-next-steps-for-tredaptive-extended-release-niacin-laropiprant/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-oxytrol-for-women-the-first-over-the-counter-treatment-for-overactive-bladder-in-women/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-launches-protectotype-an-innovative-vaccination-program-to-increase-infectious-bronchitis-protection-in-poultry/</loc>
		<lastmod>2023-03-22T04:04:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-begins-tender-offer-to-acquire-cubist/</loc>
		<lastmod>2023-03-22T04:04:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-regarding-cubicin-patent-litigation/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-investigating-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-patients-with-advanced-triple-negative-breast-cancer-presented-at-2014-san-antonio-breast-cancer-symposium/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/international-breast-cancer-study-group-breast-international-group-and-merck-announce-opening-of-international-panacea-study-of-patients-with-her2-breast-cancer/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-appointment-of-dr-julie-gerberding-as-executive-vice-president-for-strategic-communications-global-public-policy-and-population-health/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-hpv-vaccine-gardasil9-to-prevent-cancers-and-other-diseases-caused-by-nine-hpv-types-including-types-that-cause-about-90-of-cervical-cancer-cases/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-acquires-oncoethix-a-privately-held-oncology-company-developing-novel-bet-inhibitors-for-hematological-and-solid-cancers/</loc>
		<lastmod>2023-03-22T04:04:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-phase-2-study-of-investigational-chronic-hepatitis-c-treatment-grazoprevir-elbasvir-in-genotype-1-infected-treatment-naive-and-difficult-to-cure-patients/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-positive-study-investigating-the-use-of-keytruda-pembrolizumab-compared-to-chemotherapy-in-patients-with-ipilimumab-refractory-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-that-improve-it-achieved-primary-endpoint-data-to-be-presented-at-american-heart-association-scientific-sessions-today/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/vytorin-ezetimibe-simvastatin-significantly-reduced-cardiovascular-events-more-than-simvastatin-alone-in-patients-presenting-with-acute-coronary-syndromes-in-the-investigational-improve-it-stu/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-submits-new-drug-application-to-the-japanese-pharmaceuticals-and-medical-devices-agency-for-omarigliptin-an-investigational-once-weekly-dpp-4-inhibitor-for-type-2-diabetes/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-newlink-genetics-enter-into-licensing-and-collaboration-agreement-for-investigational-ebola-vaccine/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-increased-quarterly-dividend-2/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-investigating-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-patients-with-classical-hodgkin-lymphoma-presented-at-ash-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-cubist-pharmaceuticals-for-102-per-share-in-cash/</loc>
		<lastmod>2023-03-22T04:04:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2014-financial-results/</loc>
		<lastmod>2023-03-22T04:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-data-from-48-week-phase-2b-study-of-investigational-hiv-therapy-doravirine-mk-1439-in-treatment-naive-patients/</loc>
		<lastmod>2023-03-22T04:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-provides-update-on-zilmax-five-step-plan-announces-next-steps/</loc>
		<lastmod>2023-03-22T04:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-studies-investigating-the-use-of-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-advanced-melanoma-compared-to-chemotherapy-in-classical-hodgkin-lymphoma-and-in-triple-negat/</loc>
		<lastmod>2023-03-22T04:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-data-from-proof-of-concept-study-of-mercks-investigational-hepatitis-c-treatment-grazoprevir-elbasvir-in-combination-with-a-nucleotide-inhibitor-c-swift-study-presented-at-the-liver/</loc>
		<lastmod>2023-03-22T04:04:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-presentation-of-early-data-on-the-investigational-use-of-keytruda-pembrolizumab-in-patients-with-advanced-bladder-cancer-at-esmo-2014/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-completes-sale-of-consumer-care-business-to-bayer-ag-for-14-2-billion/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-congratulates-ecuador-as-second-country-to-receive-paho-who-verification-of-elimination-of-river-blindness/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-tender-offers-for-eight-series-of-notes/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-proposed-public-debt-offering/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-eur-2-5-billion-debt-offering/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-from-clinical-studies-evaluating-investigational-hepatitis-c-treatment-grazoprevir-elbasvir-mk-5172-mk-8742-at-the-65th-american-association-for-the-study-of-liver-diseases/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-pricing-of-tender-offers-for-eight-series-of-notes/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-final-results-of-tender-offers-for-eight-series-of-notes/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/us-fda-accepts-for-review-a-biologics-license-application-for-merck-and-sanofi-pasteurs-investigational-pediatric-hexavalent-vaccine/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-breakthrough-therapy-designation-for-keytruda-pembrolizumab-in-advanced-non-small-cell-lung-cancer/</loc>
		<lastmod>2023-03-22T04:04:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-in-five-tumor-types-from-studies-evaluating-pembrolizumab-the-companys-investigational-anti-pd-1-antibody-at-esmo-2014/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-beta-lactamase-inhibitor-relebactam-mk-7655-granted-qualified-infectious-disease-product-qidp-and-fast-track-designations-by-fda/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-accelerated-approval-of-keytruda-pembrolizumab-the-first-fda-approved-anti-pd-1-therapy/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-scientific-data-at-the-european-association-for-the-study-of-diabetes-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-at-the-morgan-stanley-global-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-data-from-pivotal-phase-3-fracture-outcomes-study-for-odanacatib-an-investigational-oral-once-weekly-treatment-for-osteoporosis/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/sun-pharma-and-merck-co-inc-enter-into-licensing-agreement-for-tildrakizumab/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-presents-first-phase-3-data-in-japanese-patients-for-omarigliptin-an-investigational-once-weekly-dpp-4-inhibitor-for-type-2-diabetes/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2014-sales-and-earnings-conference-call-on-october-27/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-presentation-of-data-on-the-investigational-use-of-keytruda-pembrolizumab-in-patients-with-advanced-gastric-cancer-at-esmo-2014/</loc>
		<lastmod>2023-03-22T04:04:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-initiates-phase-3-study-of-letermovir-an-investigational-antiviral-for-prevention-of-cytomegalovirus-cmv-infection-in-high-risk-bone-marrow-transplant-patients/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2014-financial-results/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/chmp-issues-positive-opinion-for-intravenous-iv-formulation-of-mercks-noxafil-posaconazole/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-completes-tender-offer-to-acquire-idenix/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-2013-global-corporate-responsibility-report/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-belsomra-suvorexant-for-the-treatment-of-insomnia/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-regarding-role-of-pneumovax-23-pneumococcal-vaccine-polyvalent-in-updated-acip-recommendations-for-pneumococcal-vaccination-in-adults/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/pfizer-and-merck-to-collaborate-on-study-evaluating-novel-anti-cancer-combination-regimen/</loc>
		<lastmod>2023-03-22T04:04:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-post-hoc-analysis-shows-patients-with-type-2-diabetes-undergoing-intensification-of-insulin-therapy-experienced-less-nighttime-hypoglycemia-while-being-treated-with-januvia-sitagliptin-com/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/late-breaking-observational-data-show-patients-with-type-2-diabetes-taking-januvia-sitagliptin-and-metformin-initiated-insulin-therapy-at-a-slower-rate-compared-to-patients-taking-a-sulfonylur/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-begins-tender-offer-to-acquire-idenix/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-names-michael-j-holston-as-future-general-counsel-will-succeed-bruce-n-kuhlik-in-july-2015/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2014-sales-and-earnings-conference-call-on-july-29/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-mercks-nda-for-fixed-dose-combination-of-raltegravir-with-lamivudine/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-anti-pd-1-antibody-pembrolizumab-under-regulatory-review-in-europe-for-the-treatment-of-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-data-from-investigational-phase-3-study-on-emend-aprepitant-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting-cinv-in-children-undergoing-emetogenic-chemotherapy/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-hiv-campaign-i-design-partners-with-music-industry-promoter-and-hiv-advocate-maria-davis-and-positive-womens-network-usa-to-encourage-women-living-with-hiv-to-be/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2014-dividend/</loc>
		<lastmod>2023-03-22T04:04:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-announces-fda-approval-of-bravecto-fluralaner/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2014-dividend/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/first-presentation-of-early-data-for-pembrolizumab-mk-3475-mercks-investigational-anti-pd-1-antibody-in-advanced-head-and-neck-cancer-at-asco-2014/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-on-mercks-pembrolizumab-from-largest-study-to-date-of-investigational-anti-pd-1-antibody-in-advanced-melanoma-highlighted-at-asco-2014/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/first-presentation-of-data-for-pembrolizumab-mercks-investigational-anti-pd-1-antibody-in-patients-with-previously-untreated-advanced-non-small-cell-lung-cancer-nsclc-at-asco-2014/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/first-patient-enrolled-in-new-phase-3-trial-program-investigating-a-once-daily-dosing-regimen-of-isentress-raltegravir/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-clinical-data-on-januvia-sitagliptin-investigational-omarigliptin-and-real-world-data-in-patients-with-type-2-diabetes-at-the-74th-scientific-sessions-of-the-americ/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-idenix/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-launches-global-patient-registry-supporting-expanded-commitment-to-real-world-outcomes-research-in-type-2-diabetes/</loc>
		<lastmod>2023-03-22T04:04:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-sale-of-consumer-care-business-to-bayer-ag-for-14-2-billion/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-for-review-of-mk-3475-biologics-license-application-for-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-progress-on-its-strategic-initiative-to-sharpen-commercial-and-rd-focus-drive-growth-and-productivity/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/aicuris-and-merck-announce-publication-in-new-england-journal-of-medicine-of-phase-2-clinical-trial-results-of-investigational-antiviral-agent-letermovir-in-bone-marrow-transplant-patients/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-zontivity-vorapaxar-first-in-class-par-1-antagonist-for-the-reduction-of-thrombotic-cardiovascular-events-in-patients-with-a-history-of-heart-attack-or-with-peripheral-arteri/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-signs-sale-agreement-with-santen-for-mercks-ophthalmology-products-in-japan-and-key-markets-in-europe-and-asia-pacific/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-anti-pd1-antibody-mk-3475-active-in-three-different-tumor-types-new-data-to-be-presented-at-the-2014-asco-annual-meeting/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/the-american-college-of-endocrinology-merck-urge-patients-with-type-2-diabetes-to-work-with-their-doctor-to-get-to-their-blood-sugar-goals/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-announce-withdrawal-of-conditional-marketing-authorization-applications-for-vintafolide-and-companion-imaging-components-etarfolatide-and-intravenous-iv-folic-acid-in-europe/</loc>
		<lastmod>2023-03-22T04:04:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-chronic-hepatitis-c-combination-therapy-mk-5172-mk-8742-demonstrates-antiviral-activity-in-hard-to-cure-patients-with-hcv-genotype-1-infection/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-grastek-timothy-grass-pollen-allergen-extract-sublingual-tablet-as-immunotherapy-to-treat-grass-pollen-induced-allergic-rhinitis-with-or-without-conjunctivitis-in/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-ragwitek-short-ragweed-pollen-allergen-extract-sublingual-tablet-as-immunotherapy-to-treat-short-ragweed-pollen-induced-allergic-rhinitis-with-or-without-conjun/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-award-winning-actress-s-epatha-merkerson-challenge-americans-with-type-2-diabetes-to-get-to-their-goals/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-investor-briefing-at-boston-research-facility/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2014-financial-results/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-announce-independent-dsmb-recommends-vintafolide-proceed-phase-3-trial-be-stopped-for-futility-following-interim-analysis/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-announce-independent-dsmb-recommends-vintafolide-proceed-phase-3-trial-be-stopped-for-futility-following-interim-analysis/</loc>
		<lastmod>2023-03-22T04:04:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-endocyte-announce-european-chmp-positive-opinions-for-vynfinit-vintafolide-and-companion-imaging-agents-folcepri-etarfolatide-and-neocepri-intravenous-iv-folic-acid/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-for-investigational-hepatitis-c-treatments-mk-5172-and-mk-8742-at-easl-annual-meeting-the-international-liver-congress-2014/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-appointment-of-robert-m-davis-as-chief-financial-officer-succeeds-peter-n-kellogg-who-has-served-in-the-role-since-2007/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2014-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-ferring-pharmaceuticals-and-the-world-health-organization-working-together-to-prevent-excessive-bleeding-in-women-after-childbirth/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/early-findings-exploring-the-relationship-of-pd-l1-expression-and-clinical-outcomes-with-mk-3475-mercks-investigational-anti-pd-1-immunotherapy-presented-at-aacr-annual-meeting-2014/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-studies-evaluating-investigational-hepatitis-c-treatments-mk-5172-and-mk-8742-in-treatment-naive-patients-with-genotype-1-infection/</loc>
		<lastmod>2023-03-22T04:04:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2014-dividend/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/study-results-show-activyl-by-merck-animal-health-outperforms-frontline-plus/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/chmp-issues-positive-opinion-for-tablet-formulation-of-mercks-noxafil-posaconazole/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-cowen-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-phase-2b-study-of-mk-8237-an-investigational-house-dust-mite-sublingual-allergen-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-96-week-actg-study-results-presented-at-croi-2014-first-large-study-comparing-isentress-raltegravir-regimen-to-two-protease-inhibitor-regimens-in-previously-untreated-adults-with-hiv-1/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-hiv-therapy-doravirine-mk-1439-demonstrates-antiviral-activity-in-phase-2b-study-of-treatment-naive-adults/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-hepatitis-c-treatment-regimen-mk-5172-mk-8742-shows-robust-anti-hcv-activity-in-hiv-hcv-co-infected-patients-with-hcv-genotype-1-infection/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-noxafil-posaconazole-injection-18-mg-ml-for-intravenous-use/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2014-sales-and-earnings-conference-call-on-april-29/</loc>
		<lastmod>2023-03-22T04:04:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-for-vorapaxar-mercks-investigational-antiplatelet-medicine/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-for-ragwitek-short-ragweed-pollen-allergen-extract-an-investigational-sublingual-allergy-immunotherapy-tablet/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-canadian-approval-of-grastek-standardized-allergenic-extract-timothy-grass-phleum-pratense-sublingual-tablet/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-enters-strategic-collaborations-with-amgen-incyte-and-pfizer-to-evaluate-novel-combination-anti-cancer-regimens-with-mk-3475/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2013-financial-results/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-samsung-bioepis-enter-collaboration-agreement-to-develop-and-commercialize-insulin-glargine-candidate-for-diabetes/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-receives-marketing-authorization-from-european-commission-for-bravecto-fluralaner/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-for-review-mercks-biologics-license-application-for-v503-investigational-9-valent-human-papillomavirus-vaccine/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-in-the-citi-2014-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:04:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-fourth-quarter-2013-sales-and-earnings-conference-call-on-february-5/</loc>
		<lastmod>2023-03-22T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-approval-for-isentress-raltegravir-for-pediatric-oral-suspension/</loc>
		<lastmod>2023-03-22T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-32nd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-initiates-rolling-submission-of-u-s-biologics-license-application-for-mk-3475-an-investigational-anti-pd-1-immunotherapy-in-patients-with-advanced-melanoma/</loc>
		<lastmod>2023-03-22T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-accelerated-strategic-actions-for-growth-at-32nd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2023-03-22T04:05:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-ranked-no-1-in-the-pharmaceutical-industry-among-barrons-100-most-sustainable-us-companies-2023/</loc>
		<lastmod>2023-04-06T02:48:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-named-one-of-fortunes-2023-100-best-companies-to-work-for/</loc>
		<lastmod>2023-04-11T17:06:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/the-inflation-reduction-acts-negative-impact-on-patient-focused-innovation-value-and-access/</loc>
		<lastmod>2023-06-06T14:18:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-ridgeback-provide-update-on-eu-marketing-authorization-application-for-lagevrio-molnupiravir-2/</loc>
		<lastmod>2023-06-27T12:26:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/our-companys-commitment-to-diversity-equity-and-inclusion/</loc>
		<lastmod>2023-07-03T17:06:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reports-strong-progress-on-its-commitments-to-advancing-access-to-health-and-operating-responsibly/</loc>
		<lastmod>2023-08-10T13:18:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-fda-advisory-committee-meeting-evaluating-gefapixant/</loc>
		<lastmod>2023-11-17T22:31:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-to-acquire-elancos-aqua-business/</loc>
		<lastmod>2024-02-05T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-to-acquire-elancos-aqua-business/</loc>
		<lastmod>2024-02-05T11:30:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-testimony-for-senate-health-education-labor-and-pensions-committee-hearing/</loc>
		<lastmod>2024-02-08T15:03:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-strengthens-its-commitment-to-expanding-access-to-care-in-asia-pacific-region/</loc>
		<lastmod>2024-03-13T14:21:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reaffirms-commitment-to-gavi-the-vaccine-alliance-to-supply-low-and-middle-income-countries-with-its-hpv-vaccine/</loc>
		<lastmod>2024-04-25T18:43:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-phase-3-keyvibe-010-trial-evaluating-an-investigational-coformulation-of-vibostolimab-and-pembrolizumab-as-adjuvant-treatment-for-patients-with-resected-high-risk-melanoma-2/</loc>
		<lastmod>2024-05-13T10:45:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/cdcs-acip-unanimously-votes-to-add-merck-and-sanofis-pediatric-hexavalent-combination-vaccine-to-its-preferential-recommendation-to-help-prevent-invasive-hib-disease-in-american-indi/</loc>
		<lastmod>2024-06-27T19:35:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/cdcs-acip-unanimously-recommends-mercks-capvaxive-pneumococcal-21-valent-conjugate-vaccine-for-pneumococcal-vaccination-in-appropriate-adults/</loc>
		<lastmod>2024-06-28T00:18:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reports-strong-momentum-in-expanding-and-enabling-access-to-health-care-driving-sustainability-and-operating-responsibly-in-2023-2024-impact-report/</loc>
		<lastmod>2024-08-19T10:38:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fdas-oncologic-drugs-advisory-committee-to-discuss-pd-l1-expression-thresholds-in-certain-advanced-gastric-gastroesophageal-junction-and-esophageal-cancer-indications-for-immune-checkpoint-i/</loc>
		<lastmod>2024-08-22T22:17:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-fdas-oncologic-drugs-advisory-committee-meeting-discussion-of-pd-l1-expression-levels-in-certain-advanced-gastric-gastroesophageal-junction-and-esophageal-cancer-ind/</loc>
		<lastmod>2024-09-26T22:25:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2021-dividend-2/</loc>
		<lastmod>2024-11-09T03:27:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-heightens-focus-on-advancing-equity-in-cardiac-care-across-the-u-s/</loc>
		<lastmod>2024-11-20T19:37:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-earns-top-spot-on-newsweeks-list-of-americas-most-responsible-companies-2025/</loc>
		<lastmod>2024-12-05T16:53:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-honors-the-life-and-legacy-of-president-jimmy-carter/</loc>
		<lastmod>2025-01-02T16:03:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-significantly-improves-survival-compared-to-chemotherapy-in-previously-treated-patients-with-non-small-cell-lung-cancer-whose-tumors-express-any-level-of/</loc>
		<lastmod>2025-03-08T04:32:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/world-health-organization-to-review-mercks-investigational-ebola-vaccine-for-emergency-use-assessment-and-listing/</loc>
		<lastmod>2025-03-08T04:32:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-european-medicines-agency-marketing-authorization-application-for-investigational-chronic-hepatitis-c-therapy-elbasvir-grazoprevir/</loc>
		<lastmod>2025-03-08T04:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-bridion-sugammadex-receives-fda-approval-for-the-reversal-of-neuromuscular-blockade-induced-by-rocuronium-and-vecuronium-in-adults-undergoing-surgery/</loc>
		<lastmod>2025-03-08T04:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-expanded-age-indication-for-gardasil-9-in-males/</loc>
		<lastmod>2025-03-08T04:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-expanded-indication-for-mercks-keytruda-pembrolizumab-for-the-treatment-of-patients-with-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-samsung-bioepis-receives-approval-of-renflexis-infliximab-a-biosimilar-of-remicade-in-korea/</loc>
		<lastmod>2025-03-08T04:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lilly-and-merck-expand-immuno-oncology-collaboration-adding-abemaciclib-and-keytruda-pembrolizumab-combination-trial/</loc>
		<lastmod>2025-03-08T04:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/findings-across-a-range-of-hematological-cancers-add-to-the-growing-breadth-of-keytruda-pembrolizumab-data/</loc>
		<lastmod>2025-03-08T04:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-on-improve-it-study-with-vytorin-ezetimibe-and-simvastatin/</loc>
		<lastmod>2025-03-08T04:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/amgen-and-merck-announce-cancer-immunotherapy-collaboration-for-patients-with-non-hodgkin-lymphoma/</loc>
		<lastmod>2025-03-08T04:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/responses-observed-in-three-quarters-of-heavily-pre-treated-multiple-myeloma-patients-receiving-keytruda-pembrolizumab-combined-with-lenalidomide-and-dexamethasone/</loc>
		<lastmod>2025-03-08T04:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-pioneers-h3n2-canine-influenza-vaccine/</loc>
		<lastmod>2025-03-08T04:32:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-increased-quarterly-dividend-3/</loc>
		<lastmod>2025-03-08T04:32:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-initial-results-for-keytruda-pembrolizumab-with-novel-immunotherapy-combinations-from-three-investigational-studies-presented-at-the-society-for-melanoma-research-international/</loc>
		<lastmod>2025-03-08T04:32:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-results-from-two-phase-2-studies-of-investigational-triple-combination-chronic-hepatitis-c-therapy-at-the-liver-meeting/</loc>
		<lastmod>2025-03-08T04:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lilly-and-merck-expand-immuno-oncology-collaboration-with-phase-iii-nonsquamous-non-small-cell-lung-cancer-trial/</loc>
		<lastmod>2025-03-08T04:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-studies-investigating-the-use-of-keytruda-pembrolizumab-across-solid-and-hematological-cancers-to-be-presented-at-upcoming-congresses/</loc>
		<lastmod>2025-03-08T04:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-phase-3-results-of-investigational-elbasvir-grazoprevir-in-people-with-chronic-hepatitis-c-genotypes-1-4-or-6-infection-who-inject-drugs-and-are-on-opioid-agonist-ther/</loc>
		<lastmod>2025-03-08T04:32:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-reveal-outcomes-study/</loc>
		<lastmod>2025-03-08T04:32:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-release-findings-from-integrated-analysis-of-six-phase-2-and-3-clinical-trials-evaluating-investigational-elbasvir-grazoprevir-in-patients-with-chronic-hepatitis-c-genotype-1-4-or-6-infectio/</loc>
		<lastmod>2025-03-08T04:32:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-to-acquire-harrisvaccines/</loc>
		<lastmod>2025-03-08T04:32:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-on-vericiguat-investigational-heart-failure-medicine-to-be-presented-as-late-breaking-clinical-trial-at-the-2015-american-heart-association-aha-scientific-sessions/</loc>
		<lastmod>2025-03-08T04:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-samsung-bioepis-will-present-new-biosimilars-data-at-the-2015-acr-arhp-annual-meeting/</loc>
		<lastmod>2025-03-08T04:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-regarding-cubicin-daptomycin-for-injection-patent-litigation/</loc>
		<lastmod>2025-03-08T04:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-for-bridion-sugammadex-investigational-agent-for-the-reversal-of-neuromuscular-blockade-nmb-induced-by-rocuronium-or-vecuronium/</loc>
		<lastmod>2025-03-08T04:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/gsk-and-merck-to-study-immunotherapy-combination-as-potential-cancer-treatment/</loc>
		<lastmod>2025-03-08T04:32:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-breakthrough-therapy-designation-from-u-s-food-and-drug-administration-for-keytruda-pembrolizumab-in-advanced-colorectal-cancer/</loc>
		<lastmod>2025-03-08T04:32:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/macrogenics-and-merck-to-collaborate-on-immuno-oncology-study-evaluating-margetuximab-in-combination-with-keytruda-pembrolizumab-for-advanced-gastric-cancer/</loc>
		<lastmod>2025-03-08T04:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-shows-superior-overall-survival-compared-to-chemotherapy-in-patients-with-previously-treated-advanced-non-small-cell-lung-cancer-whose-tumors-express-pd/</loc>
		<lastmod>2025-03-08T04:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2015-financial-results/</loc>
		<lastmod>2025-03-08T04:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-from-merck-awarded-prix-galien-usa-2015-best-biotechnology-product-award/</loc>
		<lastmod>2025-03-08T04:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/incyte-and-merck-expand-clinical-collaboration-to-include-phase-3-study-investigating-the-combination-of-epacadostat-with-keytruda-pembrolizumab-as-first-line-treatment-for-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-on-investigational-chronic-hepatitis-c-treatment-elbasvir-grazoprevir-at-the-liver-meeting-2015-including-phase-3-results-in-selected-difficult-to-treat-populations/</loc>
		<lastmod>2025-03-08T04:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-congratulates-awardees-of-2015-nobel-prize-in-physiology-or-medicine-for-discovery-leading-to-river-blindness-treatment/</loc>
		<lastmod>2025-03-08T04:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-mercks-phase-3-study-of-investigational-chronic-hepatitis-c-therapy-elbasvir-grazoprevir-in-patients-with-advanced-chronic-kidney-disease-published-in-the-lancet/</loc>
		<lastmod>2025-03-08T04:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-receives-new-draft-recommendation-from-national-institute-for-health-and-care-excellence-nice-in-u-k-for-first-line-treatment-for-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/international-coalition-urges-final-push-to-eliminate-river-blindness-from-the-americas/</loc>
		<lastmod>2025-03-08T04:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-dnatrix-announce-phase-2-immuno-oncology-collaboration-in-patients-with-aggressive-form-of-brain-cancer/</loc>
		<lastmod>2025-03-08T04:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-keytruda-pembrolizumab-for-the-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-whose-tumors-express-pd-l1-with-disease-progression-on-or-after-platinum-containing/</loc>
		<lastmod>2025-03-08T04:32:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-from-keynote-028-mercks-trial-evaluating-keytruda-pembrolizumab-across-a-range-of-cancer-types-presented-at-2015-european-cancer-congress/</loc>
		<lastmod>2025-03-08T04:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/marizev-omarigliptin-mercks-once-weekly-dpp-4-inhibitor-for-type-2-diabetes-approved-in-japan/</loc>
		<lastmod>2025-03-08T04:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/syndax-and-merck-announce-first-patients-dosed-in-phase-1b-2-clinical-trial-of-entinostat-and-keytruda/</loc>
		<lastmod>2025-03-08T04:32:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/pivotal-phase-3-studies-of-bezlotoxumab-mercks-investigational-antitoxin-to-prevent-clostridium-difficile-infection-recurrence-met-primary-endpoint/</loc>
		<lastmod>2025-03-08T04:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2015-sales-and-earnings-conference-call-on-october-27/</loc>
		<lastmod>2025-03-08T04:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-findings-show-anti-tumor-activity-of-keytruda-pembrolizumab-in-patients-with-advanced-nasopharyngeal-carcinoma/</loc>
		<lastmod>2025-03-08T04:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-findings-show-anti-tumor-activity-of-keytruda-pembrolizumab-in-patients-with-advanced-nasopharyngeal-carcinoma/</loc>
		<lastmod>2025-03-08T04:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-diabetes-portfolio-update-and-underscores-comprehensive-long-term-commitment-to-patients-with-diabetes/</loc>
		<lastmod>2025-03-08T04:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-of-phase-2-study-of-mercks-investigational-beta-lactamase-inhibitor-relebactam-presented-at-icaac-icc-2015/</loc>
		<lastmod>2025-03-08T04:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-samsung-bioepis-announce-approval-of-brenzys-etanercept-a-biosimilar-of-enbrel-in-korea/</loc>
		<lastmod>2025-03-08T04:32:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-2014-global-corporate-responsibility-report/</loc>
		<lastmod>2025-03-08T04:32:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-its-commitment-to-infectious-disease-with-40-presentations-of-data-at-icaac-icc-2015/</loc>
		<lastmod>2025-03-08T04:32:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-at-the-morgan-stanley-global-healthcare-conference-2/</loc>
		<lastmod>2025-03-08T04:32:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-omarigliptin-an-investigational-once-weekly-dpp-4-inhibitor-achieved-similar-a1c-reductions-to-januvia-sitagliptin-in-patients-with-type-2-diabetes-inadequately-controlled-on/</loc>
		<lastmod>2025-03-08T04:32:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-analyses-from-the-improve-it-outcomes-study-of-vytorin-ezetimibe-and-simvastatin-and-the-tecos-cardiovascular-safety-trial-of-januvia-sitagliptin-will-be-presented-at-the-european/</loc>
		<lastmod>2025-03-08T04:32:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-analyses-from-the-improve-it-study-with-vytorin-ezetimibe-and-simvastatin/</loc>
		<lastmod>2025-03-08T04:32:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-pediatric-indication-for-emend-aprepitant-capsules-in-combination-with-other-antiemetic-agents/</loc>
		<lastmod>2025-03-08T04:32:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-for-first-line-treatment-of-advanced-melanoma-and-grants-priority/</loc>
		<lastmod>2025-03-08T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-recalls-temodar-and-temozolomide-bottles-with-cracked-caps-due-to-failure-to-meet-child-resistant-closure-requirement/</loc>
		<lastmod>2025-03-08T04:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/immune-design-and-merck-to-collaborate-on-combination-trials-of-two-immune-design-immunotherapies-with-mercks-keytruda-for-non-hodgkins-lymphoma-and-melanoma/</loc>
		<lastmod>2025-03-08T04:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-md-anderson-cancer-center-announce-strategic-immuno-oncology-research-collaboration-in-solid-tumors/</loc>
		<lastmod>2025-03-08T04:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2015-financial-results/</loc>
		<lastmod>2025-03-08T04:33:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/pamela-j-craig-and-dr-paul-b-rothman-elected-to-merck-board-of-directors/</loc>
		<lastmod>2025-03-08T04:33:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/in-interim-results-from-phase-3-study-mercks-investigational-ebola-vaccine-efficacious-study-is-continuing/</loc>
		<lastmod>2025-03-08T04:33:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-mercks-anti-pd-1-therapy-keytruda-pembrolizumab-for-both-first-line-and-previously-treated-patients-with-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2015-dividend/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-european-medicines-agency-acceptance-of-marketing-authorization-application-for-grazoprevir-elbasvir-an-investigational-therapy-for-treatment-of-chronic-hepatitis-c-infection/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-positive-chmp-opinion-for-investigational-antibiotic-zerbaxa-ceftolozane-and-tazobactam/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-u-s-food-and-drug-administration-acceptance-of-new-drug-application-for-grazoprevir-elbasvir-an-investigational-therapy-for-treatment-of-chronic-hepatitis-c-genotypes-1-4-and-6-infe/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-enhances-immuno-oncology-portfolio-with-acquisition-of-ccam-biotherapeutics/</loc>
		<lastmod>2025-03-08T04:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/allergan-enters-into-licensing-agreement-with-merck-to-obtain-exclusive-worldwide-rights-to-cgrp-migraine-development-program/</loc>
		<lastmod>2025-03-08T04:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-marks-30-year-milestone-in-commitment-to-innovation-and-care-in-hiv-aids/</loc>
		<lastmod>2025-03-08T04:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-samsung-bioepis-announce-pivotal-phase-3-studies-for-investigational-biosimilars-sb4-enbrel-etanercept-and-sb2-remicade-infliximab-met-primary-endpoints/</loc>
		<lastmod>2025-03-08T04:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-launches-new-program-that-encourages-women-to-rule-the-real-talk-and-prioritize-their-sexual-health/</loc>
		<lastmod>2025-03-08T04:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-manual-and-msd-manual-launch-global-medical-knowledge-2020-to-provide-free-access-to-credible-medical-information-on-every-continent-by-2020/</loc>
		<lastmod>2025-03-08T04:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2015-sales-and-earnings-conference-call-on-july-28/</loc>
		<lastmod>2025-03-08T04:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-phase-3-study-of-single-dose-emend-fosaprepitant-dimeglumine-for-injection-regimen-met-primary-endpoint-in-prevention-of-chemotherapy-induced-nausea-and-vomiting-in-patients-re/</loc>
		<lastmod>2025-03-08T04:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-advanced-non-small-cell-lung-cancer-and-grants-priority-review/</loc>
		<lastmod>2025-03-08T04:33:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-investigational-improve-it-study-of-vytorin-ezetimibe-and-simvastatin-published-in-the-new-england-journal-of-medicine/</loc>
		<lastmod>2025-03-08T04:33:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/tecos-mercks-cardiovascular-safety-trial-of-januvia-sitagliptin-met-primary-endpoint-in-patients-with-type-2-diabetes/</loc>
		<lastmod>2025-03-08T04:33:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/findings-presented-at-2015-asco-annual-meeting-add-to-breadth-of-keytruda-pembrolizumab-data-anti-tumor-activity-now-demonstrated-in-13-different-tumor-types/</loc>
		<lastmod>2025-03-08T04:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-dynavax-announce-new-collaboration-investigating-the-combination-of-immuno-oncology-therapies/</loc>
		<lastmod>2025-03-08T04:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-findings-show-durable-anti-tumor-activity-with-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-patients-with-advanced-head-and-neck-cancer-regardless-of-pd-l1-expression-sta/</loc>
		<lastmod>2025-03-08T04:33:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/tesaro-and-merck-to-collaborate-on-a-combination-study-of-niraparib-and-keytruda-pembrolizumab/</loc>
		<lastmod>2025-03-08T04:33:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/amgen-and-merck-announce-expansion-of-collaboration-to-support-studies-of-talimogene-laherparepvec-in-combination-with-keytruda-pembrolizumab-in-patients-with-head-and-neck-cancer/</loc>
		<lastmod>2025-03-08T04:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/first-study-evaluating-dna-mismatch-repair-as-genetic-guide-for-immunotherapy-treatment-with-mercks-keytruda-pembrolizumab-presented-at-2015-asco-annual-meeting-and-published-in-the-n/</loc>
		<lastmod>2025-03-08T04:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-positive-chmp-opinion-for-keytruda-pembrolizumab-for-the-treatment-of-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2015-dividend/</loc>
		<lastmod>2025-03-08T04:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-nanostring-announce-clinical-research-collaboration-to-develop-an-immune-related-gene-expression-assay-for-use-in-the-development-program-for-keytruda-pembrolizumab/</loc>
		<lastmod>2025-03-08T04:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-submits-u-s-new-drug-application-for-grazoprevir-elbasvir-an-investigational-once-daily-single-tablet-combination-therapy-for-treatment-of-chronic-hepatitis-c-genotypes-1-4-and-6-infection/</loc>
		<lastmod>2025-03-08T04:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/plexxikon-and-merck-to-collaborate-on-combination-study-evaluating-investigational-immuno-oncology-regimen/</loc>
		<lastmod>2025-03-08T04:33:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/2015-asco-annual-meeting-new-data-in-10-different-cancers-from-mercks-rapidly-expanding-immuno-oncology-research-program-for-keytruda-pembrolizumab-to-be-presented/</loc>
		<lastmod>2025-03-08T04:33:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-ubs-global-healthcare-conference-2/</loc>
		<lastmod>2025-03-08T04:33:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-phase-2-clinical-trial-results-of-investigational-chronic-hepatitis-c-therapy-grazoprevir-elbasvir-at-the-international-liver-congresstm-2015/</loc>
		<lastmod>2025-03-08T04:33:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-the-trial-evaluating-cardiovascular-outcomes-with-sitagliptin-tecos-met-primary-endpoint/</loc>
		<lastmod>2025-03-08T04:33:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-publication-of-pivotal-data-from-phase-3-clinical-studies-of-zerbaxa-ceftolozane-tazobactam-in-the-lancet-and-clinical-infectious-diseases/</loc>
		<lastmod>2025-03-08T04:33:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2015-financial-results/</loc>
		<lastmod>2025-03-08T04:33:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-pivotal-phase-3-c-edge-program-evaluating-grazoprevir-elbasvir-shows-high-sustained-virologic-responses-across-broad-range-of-patients-with-chronic-hepatitis-c-virus-infection/</loc>
		<lastmod>2025-03-08T04:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-phase-2-3-study-of-investigational-chronic-hepatitis-c-therapy-grazoprevir-elbasvir-in-patients-with-advanced-chronic-kidney-disease/</loc>
		<lastmod>2025-03-08T04:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/early-findings-with-keytruda-pembrolizumab-mercks-anti-pd-1-therapy-in-patients-with-advanced-pleural-mesothelioma-presented-at-aacr-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/tetralogic-and-merck-to-collaborate-on-the-evaluation-of-birinapant-in-combination-with-keytruda-pembrolizumab-in-solid-tumors/</loc>
		<lastmod>2025-03-08T04:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-reaffirms-continued-commitment-to-developing-innovative-medicines-for-the-treatment-of-infectious-diseases-at-25th-annual-eccmid-congress/</loc>
		<lastmod>2025-03-08T04:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/tim-mcgraw-merck-and-the-american-diabetes-association-challenge-americans-with-type-2-diabetes-to-get-to-their-a1c-goal/</loc>
		<lastmod>2025-03-08T04:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-mercks-anti-pd-1-therapy-demonstrates-superior-survival-progression-free-survival-and-overall-response-rate-compared-to-ipilimumab-an-anti-ctla-4-therapy/</loc>
		<lastmod>2025-03-08T04:33:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/treatment-of-advanced-non-small-cell-lung-cancer-nsclc-with-keytruda-pembrolizumab-presented-at-aacr-annual-meeting-and-published-in-the-new-england-journal-of-medicine/</loc>
		<lastmod>2025-03-08T04:33:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/advaxis-and-merck-announce-initiation-of-enrollment-in-the-phase-1-2-study-of-adxs-psa-in-combination-with-anti-pd-1-therapy-keytruda-pembrolizumab-for-the-treatment-of-advanced-prostate-can/</loc>
		<lastmod>2025-03-08T04:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/ebola-vaccine-trial-begins-in-sierra-leone/</loc>
		<lastmod>2025-03-08T04:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/phase-iii-trial-of-the-merck-and-newlink-genetics-investigational-ebola-vaccine-initiated-in-sierra-leone/</loc>
		<lastmod>2025-03-08T04:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-submission-of-supplemental-biologics-license-application-sbla-to-u-s-fda-for-keytruda-pembrolizumab-in-advanced-non-small-cell-lung-cancer/</loc>
		<lastmod>2025-03-08T04:33:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2015-sales-and-earnings-conference-call-on-april-28/</loc>
		<lastmod>2025-03-08T04:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/syndax-and-merck-to-collaborate-on-immuno-oncology-study-evaluating-entinostat-in-combination-with-keytruda-pembrolizumab-in-lung-cancer-and-melanoma/</loc>
		<lastmod>2025-03-08T04:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2015-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency/</loc>
		<lastmod>2025-03-08T04:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/grazoprevir-elbasvir-mercks-investigational-chronic-hepatitis-c-therapy-granted-fda-breakthrough-therapy-designations-new-phase-2-and-3-data-in-multiple-hcv-patient-types-to-be-presented-a/</loc>
		<lastmod>2025-03-08T04:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-investigating-mercks-keytruda-pembrolizumab-in-advanced-non-small-cell-lung-cancer-and-mesothelioma-to-be-presented-in-clinical-trials-plenary-session-at-aacr-2015/</loc>
		<lastmod>2025-03-08T04:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-pivotal-keynote-006-study-in-first-line-treatment-for-advanced-melanoma-met-co-primary-endpoints-and-will-be-stopped-early/</loc>
		<lastmod>2025-03-08T04:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-10-billion-share-repurchase-program/</loc>
		<lastmod>2025-03-08T04:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-collaboration-with-the-american-diabetes-association-to-educate-adults-with-diabetes-about-increased-risk-for-serious-diseases-like-pneumococcal-pneumonia/</loc>
		<lastmod>2025-03-08T04:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/two-new-post-hoc-analyses-of-tra-2p-timi-50-study-showed-zontivity-vorapaxar-added-to-aspirin-and-or-clopidogrel-reduced-acute-limb-ischemia-and-peripheral-revascularizations-respective/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-barclays-global-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-is-first-medicine-to-be-made-available-to-patients-through-u-k-early-access-to-medicines-scheme-eams-for-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-rvsv-ebov-v920-inclusion-in-guinea-study/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-regulatory-update-on-investigational-medicine-sugammadex-injection/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-analysis-from-investigational-improve-it-study-shows-vytorin-ezetimibe-simvastatin-reduced-total-initial-and-recurrent-cardiovascular-events-more-than-simvastatin-alone-in-patients-prese/</loc>
		<lastmod>2025-03-08T04:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-from-improve-it-study-of-vytorin-ezetimibe-simvastatin-and-tra-2op-timi-50-study-of-zontivity-vorapaxar-to-be-presented-at-american-college-of-cardiology-scientific-sessions/</loc>
		<lastmod>2025-03-08T04:33:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-9-valent-hpv-vaccine-gardasil9-recommended-by-cdcs-advisory-committee-on-immunization-practices-for-females-aged-9-26-and-males-aged-9-21/</loc>
		<lastmod>2025-03-08T04:33:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-35th-annual-cowen-health-care-conference/</loc>
		<lastmod>2025-03-08T04:33:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/eisai-and-merck-enter-collaboration-to-explore-novel-combination-regimens-of-anti-pd-1-therapy-with-multi-targeting-rtk-inhibitor-and-microtubule-dynamics-inhibitor-in-multiple-types-of-cancer/</loc>
		<lastmod>2025-03-08T04:33:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/ngm-and-merck-announce-broad-strategic-collaboration-to-discover-develop-and-commercialize-novel-biologic-therapeutics/</loc>
		<lastmod>2025-03-08T04:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-on-behalf-of-its-wholly-owned-subsidiary-cubist-pharmaceuticals-announces-results-of-tender-offer-for-cubists-2-50-convertible-senior-notes-due-2017-1-125-convertible-senior-notes-du/</loc>
		<lastmod>2025-03-08T04:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-collaboration-with-the-medicines-patent-pool-to-expand-access-to-pediatric-formulations-of-raltegravir-in-developing-countries/</loc>
		<lastmod>2025-03-08T04:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2015-dividend/</loc>
		<lastmod>2025-03-08T04:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lilly-merck-enter-collaboration-agreement-to-research-immuno-oncology-combination-regimens-in-multiple-types-of-cancer/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-completes-tender-offer-to-acquire-cubist/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-on-behalf-of-its-wholly-owned-subsidiary-cubist-pharmaceuticals-announces-tender-offer-for-cubists-2-50-convertible-senior-notes-due-2017-1-125-convertible-senior-notes-due-2018-and/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-chmp-issues-positive-opinion-for-investigational-antibiotic-sivextro-tedizolid-phosphate/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/ebola-vaccine-trial-opens-in-liberia/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/newlink-genetics-merck-collaboration-to-manufacture-ebola-vaccine-candidate-supported-by-30-million-government-award/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-insomnia-medicine-belsomra-suvorexant-c-iv-the-first-and-only-orexin-receptor-antagonist-now-available-in-the-united-states/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2014-financial-results/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-8-0-billion-debt-offering/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-rvsv-ebov-v920-inclusion-in-sierra-leone-ebola-trial/</loc>
		<lastmod>2025-03-08T04:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-fourth-quarter-and-full-year-2014-sales-and-earnings-conference-call-on-february-4/</loc>
		<lastmod>2025-03-08T04:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-33rd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-strategic-actions-to-transform-the-company-and-build-a-platform-for-sustained-future-growth-at-the-33rd-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-approved-as-first-anti-pd-1-therapy-in-japan-for-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc-whose-tumors-express-high-levels-of-pd/</loc>
		<lastmod>2025-03-08T04:33:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-medicines-agencys-chmp-recommends-mercks-keytruda-pembrolizumab-for-the-first-line-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-whose-tum/</loc>
		<lastmod>2025-03-08T04:33:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-keytruda-pembrolizumab-data-in-small-cell-lung-cancer-and-mesothelioma-presented-at-17th-world-conference-on-lung-cancer/</loc>
		<lastmod>2025-03-08T04:33:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-demonstrated-improved-health-related-quality-of-life-compared-to-chemotherapy-in-first-line-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-nsclc/</loc>
		<lastmod>2025-03-08T04:33:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/interim-results-from-phase-1b-2-study-evaluating-the-combination-of-mercks-keytruda-pembrolizumab-and-eisais-halaven-eribulin-mesylate-injection-in-metastatic-triple/</loc>
		<lastmod>2025-03-08T04:33:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-keytruda-pembrolizumab-findings-in-patients-with-relapsed-or-refractory-primary-mediastinal-large-b-cell-lymphoma-presented-at-58th-annual-meeting-of-the-american-society-of-hematology/</loc>
		<lastmod>2025-03-08T04:33:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-treatment-results-in-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma-chl-presented-at-58th-annual-meeting-of-the-american-society-of-hematology/</loc>
		<lastmod>2025-03-08T04:33:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-at-the-citi-2016-global-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:33:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/actress-bellamy-young-merck-and-leading-lung-cancer-advocates-urge-those-impacted-by-lung-cancer-to-test-talk-take-action/</loc>
		<lastmod>2025-03-08T04:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-to-be-presented-at-17th-world-conference-on-lung-cancer-highlight-research-across-the-spectrum-of-thoracic-malignancies/</loc>
		<lastmod>2025-03-08T04:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-grants-priority-review-to-supplemental-biologics-license-application-sbla-for-mercks-keytruda-pembrolizumab-in-relapsed-or-refractory-classical-hodgkin-lymphoma/</loc>
		<lastmod>2025-03-08T04:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-announces-10-million-initiative-to-improve-access-to-high-quality-diabetes-care-in-vulnerable-and-underserved-u-s-communities/</loc>
		<lastmod>2025-03-08T04:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-in-blood-cancers-to-be-presented-at-58th-annual-meeting-of-the-american-society-of-hematology/</loc>
		<lastmod>2025-03-08T04:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-increased-quarterly-dividend-4/</loc>
		<lastmod>2025-03-08T04:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-sbla-seeking-approval-for-keytruda-pembrolizumab-for-new-indication-in-microsatellite-instability-hig/</loc>
		<lastmod>2025-03-08T04:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-significantly-improves-overall-survival-compared-to-chemotherapy-in-previously-treated-patients-with-advanced-bladder-urothelial-cancer/</loc>
		<lastmod>2025-03-08T04:33:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-findings-for-investigational-triple-combination-chronic-hepatitis-c-therapy-showing-high-rates-of-sustained-virologic-response-in-people-with-genotypes-1-2-or-3-infection/</loc>
		<lastmod>2025-03-08T04:33:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-fighting-infectious-diseases-with-more-than-30-data-presentations-at-id-week-2016/</loc>
		<lastmod>2025-03-08T04:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-prices-eur-1-0-billion-debt-offering/</loc>
		<lastmod>2025-03-08T04:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-scientists-publish-new-research-detailing-the-early-development-of-verubecestat-an-investigational-bace1-inhibitor-in-science-translational-medicine/</loc>
		<lastmod>2025-03-08T04:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-accepted-for-presentation-at-sitc-2016-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-new-findings-for-zepatier-elbasvir-and-grazoprevir-in-patients-with-chronic-hepatitis-c-at-the-liver-meeting/</loc>
		<lastmod>2025-03-08T04:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keynote-045-studying-keytruda-pembrolizumab-in-advanced-bladder-cancer-urothelial-cancer-meets-primary-endpoint-and-stops-early/</loc>
		<lastmod>2025-03-08T04:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-zinplava-bezlotoxumab-to-reduce-recurrence-of-clostridium-difficile-infection-cdi-in-adult-patients-receiving-antibacterial-drug-treatment-for-cdi-who-are-at/</loc>
		<lastmod>2025-03-08T04:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-in-metastatic-nsclc-for-first-line-treatment-of-patients-whose-tumors-have-high-pd-l1-expression-tumor-proportion-score-tps-of-50-percent/</loc>
		<lastmod>2025-03-08T04:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2016-financial-results/</loc>
		<lastmod>2025-03-08T04:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/two-major-studies-to-be-presented-at-esmo-2016-congress-presidential-symposium-demonstrate-potential-of-mercks-keytruda-pembrolizumab-for-the-first-line-treatment-of-metastatic-non-sm/</loc>
		<lastmod>2025-03-08T04:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-launches-biosimilars-clarified-a-new-online-educational-resource-about-biosimilar-medicines-for-patients-and-the-healthcare-community/</loc>
		<lastmod>2025-03-08T04:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-research-laboratories-facilities-designated-as-milestones-in-microbiology-sites-by-the-american-society-for-microbiology/</loc>
		<lastmod>2025-03-08T04:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-pivotal-phase-3-study-of-letermovir-an-investigational-antiviral-medicine-for-prevention-of-cytomegalovirus-cmv-infection-in-high-risk-bone-marrow-transplant-patients-met-primary-e/</loc>
		<lastmod>2025-03-08T04:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-longer-term-follow-up-of-overall-survival-data-for-keytruda-pembrolizumab-in-patients-with-advanced-melanoma-from-keynote-002-presented-at-esmo-2016-congress/</loc>
		<lastmod>2025-03-08T04:33:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-showed-continued-overall-survival-benefit-compared-to-chemotherapy-with-longer-follow-up-in-patients-with-previously-treated-metastatic-non-small-cell-lung-cancer-in-dat/</loc>
		<lastmod>2025-03-08T04:33:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-grant-expands-ymcas-diabetes-prevention-program-in-five-states/</loc>
		<lastmod>2025-03-08T04:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-congratulates-guatemala-as-fourth-country-in-latin-america-to-achieve-who-verification-of-elimination-of-river-blindness/</loc>
		<lastmod>2025-03-08T04:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-on-zepatier-elbasvir-and-grazoprevir-and-chronic-hepatitis-c-clinical-development-programs-at-the-liver-meeting-2016/</loc>
		<lastmod>2025-03-08T04:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-announces-usda-approval-of-innovative-canine-flu-bivalent-vaccine/</loc>
		<lastmod>2025-03-08T04:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-in-advanced-urothelial-cancer-demonstrate-overall-response-rate-of-24-percent-in-cisplatin-ineligible-patients/</loc>
		<lastmod>2025-03-08T04:33:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-pfizer-announce-investigational-ertugliflozin-met-primary-endpoint-of-a1c-reduction-when-added-to-sitagliptin-and-metformin-in-people-with-type-2-diabetes/</loc>
		<lastmod>2025-03-08T04:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-host-investor-teleconference-to-discuss-esmo-2016-highlights/</loc>
		<lastmod>2025-03-08T04:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2016-sales-and-earnings-conference-call-on-october-25/</loc>
		<lastmod>2025-03-08T04:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/two-new-trials-of-mercks-keytruda-pembrolizumab-as-monotherapy-and-in-combination-with-chemotherapy-for-first-line-treatment-of-patients-with-advanced-non-small-cell-lung-cancer-to-be/</loc>
		<lastmod>2025-03-08T04:33:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-2015-2016-global-corporate-responsibility-report/</loc>
		<lastmod>2025-03-08T04:33:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-u-s-fda-filing-acceptance-of-new-drug-application-nda-for-mk-1293-an-investigational-follow-on-biologic-insulin-glargine/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-patients-with-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-with-disease-progression-on-or-after-platinum-containing-che/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-from-mercks-phase-3-study-evaluating-zepatier-elbasvir-and-grazoprevir-in-patients-with-chronic-hepatitis-c-receiving-treatment-for-opioid-dependence-published-in-annals-of/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-odanacatib-development-program/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-assigns-priority-review-and-grants-breakthrough-therapy-designation-to-mercks-keytruda-pembrolizumab-for-first-line-treatment-o/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-at-the-morgan-stanley-global-healthcare-conference-3/</loc>
		<lastmod>2025-03-08T04:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2016-dividend/</loc>
		<lastmod>2025-03-08T04:33:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2016-financial-results/</loc>
		<lastmod>2025-03-08T04:33:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-approved-by-the-european-commission-for-patients-with-advanced-non-small-cell-lung-cancer-nsclc-whose-tumors-express-pd-l1/</loc>
		<lastmod>2025-03-08T04:33:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-announces-agreement-to-acquire-controlling-interest-in-brazilian-animal-health-company-vallee-s-a/</loc>
		<lastmod>2025-03-08T04:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-regulatory-update-on-biologics-licensing-application-for-investigational-agent-bezlotoxumab/</loc>
		<lastmod>2025-03-08T04:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-receives-fda-approval-of-bravecto-fluralaner-topical-solution-for-cats-and-dogs/</loc>
		<lastmod>2025-03-08T04:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-for-mercks-investigational-once-daily-formulation-of-isentress-raltegravir-show-that-at-week-48-a-regimen-containing-the-once-daily-dosing-formulation/</loc>
		<lastmod>2025-03-08T04:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-breakthrough-therapy-designation-from-fda-and-prime-status-from-ema-for-investigational-ebola-zaire-vaccine-v920/</loc>
		<lastmod>2025-03-08T04:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-moderna-announce-strategic-collaboration-to-advance-novel-mrna-based-personalized-cancer-vaccines-with-keytruda-pembrolizumab-for-the-treatment-of-multiple-types-of-cancer/</loc>
		<lastmod>2025-03-08T04:33:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-premier-inc-collaborate-to-prevent-fractures-for-osteoporosis-patients/</loc>
		<lastmod>2025-03-08T04:33:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/results-of-phase-2-study-of-mercks-investigational-beta-lactamase-inhibitor-relebactam-in-combination-with-imipenem-cilastatin-presented-at-asm-microbe/</loc>
		<lastmod>2025-03-08T04:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2016-sales-and-earnings-conference-call-on-july-29/</loc>
		<lastmod>2025-03-08T04:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-chmp-positive-opinion-for-keytruda-pembrolizumab-for-the-treatment-of-advanced-non-small-cell-lung-cancer-nsclc/</loc>
		<lastmod>2025-03-08T04:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-demonstrates-superior-progression-free-and-overall-survival-compared-to-chemotherapy-as-first-line-treatment-in-patients-with-advanced-non-small-cel/</loc>
		<lastmod>2025-03-08T04:33:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/systematic-review-of-58-publications-of-real-world-use-of-gardasil-presented-at-eurogin-congress/</loc>
		<lastmod>2025-03-08T04:33:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-pfizer-announce-two-pivotal-phase-3-studies-for-ertugliflozin-an-investigational-sglt-2-inhibitor-met-primary-endpoints-showing-significant-a1c-reductions-in-patients-with-type-2-diabetes/</loc>
		<lastmod>2025-03-08T04:33:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-insulin-glargine-mk-1293-met-primary-endpoint-in-two-phase-3-studies-showing-non-inferiority-to-lantus/</loc>
		<lastmod>2025-03-08T04:33:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-fighting-infectious-diseases-with-more-than-30-data-presentations-at-asm-microbe-2016/</loc>
		<lastmod>2025-03-08T04:33:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/keytruda-pembrolizumab-shows-overall-response-rates-of-73-to-83-percent-with-complete-response-rates-of-27-to-30-percent-in-heavily-pre-treated-patients-with-chl-in-update-to-study-kn-087/</loc>
		<lastmod>2025-03-08T04:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-findings-from-keynote-012-for-keytruda-pembrolizumab-show-continued-benefit-in-response-rates-and-duration-of-response-lasting-up-to-30-months-in-patients-with-previously-treated-recur/</loc>
		<lastmod>2025-03-08T04:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-fda-advisory-committee-meeting-for-zinplava-bezlotoxumab-an-investigational-agent-for-prevention-of-clostridium-difficile-infection-recurrence/</loc>
		<lastmod>2025-03-08T04:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-afferent-pharmaceuticals/</loc>
		<lastmod>2025-03-08T04:33:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-from-keynote-010-and-keynote-001-in-advanced-non-small-cell-lung-cancer-including-survival-data-to-be-presented-at-2016-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-evaluating-keytruda-pembrolizumab-in-combination-with-chemotherapy-for-first-line-treatment-of-non-small-cell-lung-cancer-demonstrate-response-rates-ranging-from-48-to-71-percent/</loc>
		<lastmod>2025-03-08T04:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-for-keytruda-pembrolizumab-in-combination-with-talimogene-laherparepvec-dabrafenib-plus-trametinib-or-low-dose-ipilimumab-in-advanced-melanoma-presented-at-2016-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-from-phase-2-study-evaluating-keytruda-pembrolizumab-for-the-treatment-of-cancers-deficient-in-dna-mismatch-repair-show-durable-responses-across-a-range-of-cancers/</loc>
		<lastmod>2025-03-08T04:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-accepts-samsung-bioepis-biologics-license-application-bla-for-sb2-infliximab-an-investigational-biosimilar-of-remicade/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-receives-marketing-approval-from-european-medicines-agency-for-bravecto-fluralaner-spot-on-solution-for-cats-and-dogs/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-ubs-global-healthcare-conference-3/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2016-dividend/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-positive-chmp-opinion-for-zepatier-elbasvir-and-grazoprevir-in-the-european-union/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-investor-briefing-at-2016-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-from-keynote-006-and-keynote-001-in-advanced-melanoma-including-updated-survival-data-to-be-presented-at-2016-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-announces-the-alliance-to-advance-patient-centered-cancer-care-a-15-million-initiative-to-improve-access-to-high-quality-cancer-care-in-underserved-communities-in-the-united-states/</loc>
		<lastmod>2025-03-08T04:33:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-phase-3-data-on-investigational-medicines-ertugliflozin-and-mk-1293-at-the-76th-scientific-sessions-of-the-american-diabetes-association/</loc>
		<lastmod>2025-03-08T04:33:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-keytruda-pembrolizumab-data-at-2016-asco-annual-meeting-includes-three-year-overall-survival-data-in-melanoma-and-updated-overall-survival-data-in-non-small-cell-lung-cancer-as-well-as-upd/</loc>
		<lastmod>2025-03-08T04:33:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-to-acquire-worldwide-rights-to-whisper-veterinary-stethoscope-system/</loc>
		<lastmod>2025-03-08T04:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/christina-applegate-and-merck-urge-insomnia-sufferers-to-learn-why-theyre-so-awake/</loc>
		<lastmod>2025-03-08T04:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-deutsche-bank-41st-annual-health-care-conference/</loc>
		<lastmod>2025-03-08T04:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2016-financial-results/</loc>
		<lastmod>2025-03-08T04:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-zepatier-elbasvir-and-grazoprevir-showed-superiority-on-efficacy-and-safety-endpoints-compared-to-sofosbuvir-plus-peginterferon-and-ribavirin-treatment-regimen-in-phase-3-tr/</loc>
		<lastmod>2025-03-08T04:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-in-recurrent-or-metastatic-head-and-neck-cancer-and-grants-priority-review/</loc>
		<lastmod>2025-03-08T04:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-from-phase-3-studies-of-zepatier-elbasvir-and-grazoprevir-in-chronic-hepatitis-c-patient-populations-at-the-international-liver-congress/</loc>
		<lastmod>2025-03-08T04:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-breakthrough-therapy-designation-from-u-s-food-and-drug-administration-for-keytruda-pembrolizumab-in-classical-hodgkin-lymphoma-chl/</loc>
		<lastmod>2025-03-08T04:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-statement-on-blueprint-project-findings-presented-at-the-american-association-for-cancer-research-2016-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-for-keytruda-pembrolizumab-at-the-american-association-for-cancer-research-2016-annual-meeting/</loc>
		<lastmod>2025-03-08T04:33:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-fighting-infectious-diseases-with-more-than-30-data-presentations-at-eccmid-2016/</loc>
		<lastmod>2025-03-08T04:33:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2016-sales-and-earnings-conference-call-on-may-5/</loc>
		<lastmod>2025-03-08T04:33:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-biologics-license-application-for-investigational-house-dust-mite-sublingual-allergy-immunotherapy-tablet/</loc>
		<lastmod>2025-03-08T04:33:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-awards-grant-to-american-cancer-society-for-program-to-improve-access-to-high-quality-cancer-care-in-underserved-communities/</loc>
		<lastmod>2025-03-08T04:33:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-findings-from-chronic-hepatitis-c-clinical-development-programs-at-the-international-liver-congresstm-2016/</loc>
		<lastmod>2025-03-08T04:33:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2016-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency/</loc>
		<lastmod>2025-03-08T04:33:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/sanofi-pasteur-and-merck-known-as-msd-outside-the-united-states-and-canada-announce-intent-to-end-joint-vaccines-operations-in-europe-sanofi-pasteur-msd-to-pursue-their-own-distinct-growth-strateg/</loc>
		<lastmod>2025-03-08T04:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-applauds-the-u-s-department-of-veterans-affairs-va-for-broadening-treatment-access-for-veterans-with-chronic-hepatitis-c-infection/</loc>
		<lastmod>2025-03-08T04:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/sanofi-pasteur-and-merck-known-as-msd-outside-the-united-states-and-canada-announce-intent-to-end-joint-vaccines-operations-in-europe-sanofi-pasteur-msd-to-pursue-their-own-distinct-growth-strateg/</loc>
		<lastmod>2025-03-08T04:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-applauds-the-u-s-department-of-veterans-affairs-va-for-broadening-treatment-access-for-veterans-with-chronic-hepatitis-c-infection/</loc>
		<lastmod>2025-03-08T04:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-receives-positive-final-opinion-from-european-medicines-agency-for-bravecto-fluralaner-spot-on-for-cats-and-dogs/</loc>
		<lastmod>2025-03-08T04:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-once-daily-formulation-of-isentress-raltegravir-meets-primary-and-secondary-endpoints-in-pivotal-phase-3-study/</loc>
		<lastmod>2025-03-08T04:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2016-dividend/</loc>
		<lastmod>2025-03-08T04:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-the-mectizan-donation-program-donate-1-million-to-the-end-fund-for-efforts-to-help-eliminate-river-blindness-in-africa/</loc>
		<lastmod>2025-03-08T04:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-single-dose-emend-fosaprepitant-dimeglumine-for-injection-in-combination-with-other-antiemetic-agents-for-the-prevention-of-delayed-nausea-and-vomiting-in-adults/</loc>
		<lastmod>2025-03-08T04:33:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-pet-diabetes-tracker-from-merck-animal-health-helps-owners-of-diabetic-pets-manage-the-disease/</loc>
		<lastmod>2025-03-08T04:33:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-complete-response-letter-from-the-u-s-fda-for-zetia-ezetimibe-and-vytorin-ezetimibe-and-simvastatin/</loc>
		<lastmod>2025-03-08T04:33:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-completes-enrollment-in-pivotal-phase-3-epoch-trial-investigating-the-efficacy-and-safety-of-verubecestat-in-patients-with-mild-to-moderate-alzheimers-disease/</loc>
		<lastmod>2025-03-08T04:33:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-approval-of-zepatier-elbasvir-and-grazoprevir-for-the-treatment-of-chronic-hepatitis-c-virus-genotype-1-or-4-infection-in-adults-following-priority-review/</loc>
		<lastmod>2025-03-08T04:33:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2015-financial-results/</loc>
		<lastmod>2025-03-08T04:33:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-for-keytruda-pembrolizumab-in-a-range-of-gastrointestinal-cancers-to-be-presented-at-2016-gastrointestinal-cancers-symposium/</loc>
		<lastmod>2025-03-08T04:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fda-acceptance-of-biologics-license-application-for-bezlotoxumab-an-investigational-antitoxin-for-prevention-of-clostridium-difficile-infection-recurrence/</loc>
		<lastmod>2025-03-08T04:34:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-goldman-sachs-healthcare-ceos-unscripted-a-view-from-the-top/</loc>
		<lastmod>2025-03-08T04:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-fourth-quarter-and-full-year-2015-sales-and-earnings-conference-call-on-february-3/</loc>
		<lastmod>2025-03-08T04:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-34th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-acquires-iomet-pharma-and-expands-immuno-oncology-development-program/</loc>
		<lastmod>2025-03-08T04:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-resolves-previously-disclosed-securities-class-action-lawsuit-related-to-vioxx/</loc>
		<lastmod>2025-03-08T04:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-commemorates-30-years-of-mectizan-donation-program-progress/</loc>
		<lastmod>2025-03-08T04:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-england-journal-of-medicine-publishes-phase-3-clinical-study-of-prevymis-letermovir-mercks-new-cmv-prophylaxis-medicine/</loc>
		<lastmod>2025-03-08T04:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-sbla-assigns-priority-review-to-mercks-keytruda-pembrolizumab-for-treatment-of-relapsed-or-refractory-primary-mediastinal-lar/</loc>
		<lastmod>2025-03-08T04:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-keynote-061-a-phase-3-study-of-keytruda-pembrolizumab-in-previously-treated-patients-with-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc>
		<lastmod>2025-03-08T04:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-sglt2-inhibitor-steglatro-ertugliflozin-and-fixed-dose-combination-steglujan-ertugliflozin-and-sitagliptin-for-adults-with-type-2-diabetes/</loc>
		<lastmod>2025-03-08T04:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-approval-for-isentress-raltegravir-in-combination-with-other-antiretroviral-agents-for-the-treatment-of-hiv-1-infection-in-newborns-weighing-at-least-2-kg/</loc>
		<lastmod>2025-03-08T04:34:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-and-updated-data-for-mercks-keytruda-pembrolizumab-and-updated-data-on-lynparza-olaparib-in-multiple-breast-cancer-subtypes-to-be-presented-at-the-2017-san-antonio-breast/</loc>
		<lastmod>2025-03-08T04:34:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-any-and-all-tender-offers/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-approval-of-prevymis-letermovir-for-prevention-of-cytomegalovirus-cmv-infection-and-disease-in-adult-allogeneic-stem-cell-transplant-patients/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-positive-chmp-opinion-for-prevymis-letermovir-in-the-european-union/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-pricing-of-any-and-all-tender-offers/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-final-results-of-any-and-all-tender-offers/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-increased-quarterly-dividend-and-10-billion-share-repurchase-authorization/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/impassioned-lung-cancer-survivors-join-your-cancer-game-plan-merck-to-advocate-for-others-facing-this-highly-stigmatized-disease/</loc>
		<lastmod>2025-03-08T04:34:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/astrazeneca-and-merck-rapidly-advance-lynparza-olaparib-in-japan-with-a-second-regulatory-submission/</loc>
		<lastmod>2025-03-08T04:34:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2017-financial-results/</loc>
		<lastmod>2025-03-08T04:34:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-european-application-for-keytruda-pembrolizumab-in-combination-with-pemetrexed-and-carboplatin-for-first-line-treatment-of-nonsquamous-non-small-cell-lung-cancer-nscl/</loc>
		<lastmod>2025-03-08T04:34:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-annual-corporate-responsibility-report/</loc>
		<lastmod>2025-03-08T04:34:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/u-s-fda-accepts-regulatory-submission-for-lynparza-olaparib-in-metastatic-breast-cancer-and-grants-priority-review/</loc>
		<lastmod>2025-03-08T04:34:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-launches-five-year-initiative-to-improve-diabetes-care-for-vulnerable-and-underserved-u-s-communities/</loc>
		<lastmod>2025-03-08T04:34:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/real-world-study-shows-zepatier-elbasvir-and-grazoprevir-resulted-in-high-rates-of-sustained-virologic-response-in-patients-with-chronic-hepatitis-c-infection-who-have-chronic-kidney-disease/</loc>
		<lastmod>2025-03-08T04:34:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-makes-3-million-charitable-donation-to-support-swim-across-america/</loc>
		<lastmod>2025-03-08T04:34:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-more-than-doubled-median-overall-survival-compared-to-chemotherapy-after-two-years-of-follow-up-in-first-line-treatment-of-patients-with-metastatic-non-s/</loc>
		<lastmod>2025-03-08T04:34:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/six-year-efficacy-data-for-gardasil-9-presented-at-eurogin-2017-congress/</loc>
		<lastmod>2025-03-08T04:34:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-anacetrapib-development-program/</loc>
		<lastmod>2025-03-08T04:34:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-joins-with-the-american-liver-foundation-to-educate-u-s-veterans-on-chronic-hepatitis-c-virus-hcv-infection/</loc>
		<lastmod>2025-03-08T04:34:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-and-updated-clinical-data-on-mercks-keytruda-pembrolizumab-to-be-presented-at-18th-world-conference-on-lung-cancer/</loc>
		<lastmod>2025-03-08T04:34:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-discontinues-mk-3682b-and-mk-3682c-development-programs/</loc>
		<lastmod>2025-03-08T04:34:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-on-zepatier-elbasvir-and-grazoprevir-for-the-treatment-of-chronic-hepatitis-c-virus-infection-at-the-liver-meeting-2017/</loc>
		<lastmod>2025-03-08T04:34:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-fighting-infectious-diseases-with-40-data-presentations-at-id-week-2017/</loc>
		<lastmod>2025-03-08T04:34:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-previously-treated-patients-with-recurrent-locally-advanced-or-metastatic-gastric-or-gastroesophageal-junction-cancer-whose-tumors-expre/</loc>
		<lastmod>2025-03-08T04:34:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2017-sales-and-earnings-conference-call-on-october-27/</loc>
		<lastmod>2025-03-08T04:34:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-extends-commitment-to-fighting-rabies-in-the-worlds-most-at-risk-regions/</loc>
		<lastmod>2025-03-08T04:34:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-continues-to-show-overall-survival-benefit-over-chemotherapy-with-nearly-two-years-follow-up-in-previously-treated-patients-with-advanced-urothelial-carc/</loc>
		<lastmod>2025-03-08T04:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-findings-from-phase-3-study-of-keytruda-pembrolizumab-compared-to-standard-of-care-in-patients-with-previously-treated-recurrent-or-metastatic-head-and-neck-squamous-cell-car/</loc>
		<lastmod>2025-03-08T04:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/pro-baseball-hall-of-famer-and-cancer-survivor-mike-schmidt-joins-merck-jim-kelly-and-leading-cancer-organizations-to-expand-your-cancer-game-plan-to-help-more-people-impacted-by-cancer/</loc>
		<lastmod>2025-03-08T04:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-plus-pemetrexed-and-carboplatin-pem-carbo-demonstrated-continued-benefit-in-overall-response-rates-and-progression-free-survival-compared-to-pem-carbo/</loc>
		<lastmod>2025-03-08T04:34:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/progression-free-survival-data-from-echo-202-trial-of-incytes-epacadostat-in-combination-with-mercks-keytruda-pembrolizumab-underscore-durability-of-response-in-patients-wi/</loc>
		<lastmod>2025-03-08T04:34:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-mercks-keytruda-pembrolizumab-for-the-treatment-of-certain-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma-a-type-of-bladder-cancer/</loc>
		<lastmod>2025-03-08T04:34:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-rigontec-rig-i-therapeutics-pioneer-advancing-leadership-in-immuno-oncology/</loc>
		<lastmod>2025-03-08T04:34:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-morgan-stanley-15th-annual-global-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:34:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-data-for-mercks-keytruda-pembrolizumab-in-patients-with-advanced-gastric-cancer-across-treatment-settings-to-be-presented-at-esmo-2017-congress/</loc>
		<lastmod>2025-03-08T04:34:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-results-of-reveal-outcomes-study-of-anacetrapib-investigational-medicine-for-cardiovascular-disease/</loc>
		<lastmod>2025-03-08T04:34:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-and-updated-data-for-keytruda-pembrolizumab-from-mercks-extensive-immuno-oncology-program-to-be-presented-at-the-esmo-2017-congress/</loc>
		<lastmod>2025-03-08T04:34:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2017-financial-results/</loc>
		<lastmod>2025-03-08T04:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-animal-health-to-purchase-manufacturing-facility-in-krems-austria/</loc>
		<lastmod>2025-03-08T04:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lynparza-receives-additional-and-broad-approval-in-the-u-s-for-ovarian-cancer/</loc>
		<lastmod>2025-03-08T04:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-phase-3-study-of-keytruda-pembrolizumab-monotherapy-in-patients-with-previously-treated-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-hnscc/</loc>
		<lastmod>2025-03-08T04:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-investigational-nnrti-doravirine-meets-primary-efficacy-endpoint-of-non-inferiority-to-efavirenz-both-in-combination-with-other-antiretroviral-agents-in-pivotal-phase-3-trial-for-t/</loc>
		<lastmod>2025-03-08T04:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-2017-dividend/</loc>
		<lastmod>2025-03-08T04:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/astrazeneca-and-merck-establish-strategic-oncology-collaboration/</loc>
		<lastmod>2025-03-08T04:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mandy-moore-and-merck-encourage-women-to-plan-ahead-in-her-life-her-adventures-campaign/</loc>
		<lastmod>2025-03-08T04:34:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-medicines-agencys-chmp-recommends-approval-for-mercks-keytruda-pembrolizumab-for-the-treatment-of-certain-patients-with-locally-advanced-or-metastatic-urothelial-car/</loc>
		<lastmod>2025-03-08T04:34:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-week-96-results-from-oncemrk-a-study-evaluating-once-daily-isentress-hd-raltegravir-in-combination-with-other-antiretroviral-agents-for-the-treatment-of-hiv-1-infection-in-a/</loc>
		<lastmod>2025-03-08T04:34:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-u-s-launch-of-renflexis-infliximab-abda-a-biosimilar-of-remicade-for-all-eligible-indications/</loc>
		<lastmod>2025-03-08T04:34:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-premier-inc-expand-collaboration-to-address-chronic-care-and-vaccination-rates/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-reveal-outcomes-study-of-anacetrapib/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-further-update-on-three-multiple-myeloma-studies-evaluating-keytruda-pembrolizumab-in-combination-with-pomalidomide-or-lenalidomide/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-from-clinical-trials-evaluating-isentress-hd-raltegravir-and-investigational-hiv-therapies-doravirine-and-mk-8591-at-ias-2017/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-second-quarter-2017-sales-and-earnings-conference-call-on-july-28/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentations-of-clinical-and-real-world-data-at-the-alzheimers-association-international-conference/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-u-s-fda-grants-tentative-approval-for-lusduna-nexvue-insulin-glargine-injection-a-follow-on-biologic-basal-insulin/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-pfizer-collaborate-with-corning-to-modernize-pharmaceutical-glass-packaging/</loc>
		<lastmod>2025-03-08T04:34:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-data-from-keynote-024-show-continued-overall-survival-benefit-of-mercks-keytruda-pembrolizumab-compared-to-chemotherapy-in-the-first-line-treatment-of-patients-with-metastatic/</loc>
		<lastmod>2025-03-08T04:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-pfizer-announce-that-investigational-sglt-2-inhibitor-ertugliflozin-met-primary-endpoint-in-two-phase-3-studies/</loc>
		<lastmod>2025-03-08T04:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-multiple-myeloma-studies-keynote-183-and-185-of-keytruda-pembrolizumab-in-combination-with-other-therapies/</loc>
		<lastmod>2025-03-08T04:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/updated-data-from-echo-202-trial-of-incytes-epacadostat-in-combination-with-mercks-keytruda-pembrolizumab-demonstrate-clinical-activity-across-multiple-tumor-types/</loc>
		<lastmod>2025-03-08T04:34:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-from-phase-2-i-spy-2-trial-shows-improved-outcomes-with-combination-of-mercks-keytruda-pembrolizumab-plus-standard-neoadjuvant-therapy-in-patients-with-high-risk-breast-cance/</loc>
		<lastmod>2025-03-08T04:34:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/combination-of-incytes-epacadostat-plus-mercks-keytruda-pembrolizumab-demonstrates-activity-in-clinical-trial-of-patients-with-advanced-non-small-cell-lung-cancer-nsclc/</loc>
		<lastmod>2025-03-08T04:34:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/with-more-than-one-year-follow-up-mercks-keytruda-pembrolizumab-shows-continued-overall-survival-benefit-over-chemotherapy-as-second-line-treatment-for-advanced-urothelial-carcinoma/</loc>
		<lastmod>2025-03-08T04:34:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-monotherapy-data-for-mercks-keytruda-pembrolizumab-in-heavily-pre-treated-patients-with-advanced-gastric-cancer-to-be-presented-at-2017-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:34:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/longer-term-follow-up-data-with-mercks-keytruda-pembrolizumab-in-combination-with-pemetrexed-and-carboplatin-in-first-line-nonsquamous-metastatic-non-small-cell-lung-cancer-nsclc-to/</loc>
		<lastmod>2025-03-08T04:34:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-show-durability-of-response-for-mercks-keytruda-pembrolizumab-in-advanced-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr-solid-tumors-regardless/</loc>
		<lastmod>2025-03-08T04:34:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-enters-exclusive-worldwide-license-agreement-with-teijin-pharma-for-investigational-antibody-candidate-targeting-tau/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-adult-and-pediatric-patients-with-unresectable-or-metastatic-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-dmmr/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-approval-of-isentress-hd-raltegravir-a-new-once-daily-option-in-combination-with-other-antiretroviral-agents-for-the-treatment-of-hiv-1-infection-in-appropriate-patients/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-highlights-ongoing-commitment-to-fighting-infectious-diseases-with-more-than-20-data-presentations-at-asm-microbe-2017/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-bernsteins-33rd-annual-strategic-decisions-conference/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/with-nearly-three-years-of-follow-up-keytruda-pembrolizumab-data-demonstrated-improved-survival-benefit-compared-to-ipilimumab-in-advanced-melanoma/</loc>
		<lastmod>2025-03-08T04:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-for-treatment-of-recurrent-or-advanced-gastric-or-gastroesophageal-ju/</loc>
		<lastmod>2025-03-08T04:34:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2017-dividend/</loc>
		<lastmod>2025-03-08T04:34:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-adult-and-pediatric-patients-with-unresectable-or-metastatic-microsatellite-instability-high-msi-h-or-mismatch-repair-deficient-cance/</loc>
		<lastmod>2025-03-08T04:34:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-for-keytruda-pembrolizumab-across-16-types-of-cancer-from-mercks-industry-leading-immuno-oncology-program-to-be-presented-at-the-2017-asco-annual-meeting/</loc>
		<lastmod>2025-03-08T04:34:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-certain-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma-a-type-of-bladder-cancer/</loc>
		<lastmod>2025-03-08T04:34:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-chmp-positive-opinion-recommending-approval-of-isentress-raltegravir-600-mg-in-the-european-union/</loc>
		<lastmod>2025-03-08T04:34:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-presentation-of-phase-2-results-for-mk-7264-an-investigational-p2x3-receptor-antagonist-being-evaluated-for-the-treatment-of-chronic-cough/</loc>
		<lastmod>2025-03-08T04:34:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-keytruda-pembrolizumab-for-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma-who-failed-autologous-stem-cell-transplant-and-brentuximab-vedotin-bv/</loc>
		<lastmod>2025-03-08T04:34:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-as-first-line-combination-therapy-with-pemetrexed-and-carboplatin-for-patients-with-metastatic-nonsquamous-non-small-cell-lung-cancer-nsclc/</loc>
		<lastmod>2025-03-08T04:34:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-phase-3-data-on-investigational-ertugliflozin-additional-analyses-of-studies-of-januvia-sitagliptin-and-real-world-evidence-research-at-the-77th-scientific-sessions-of-t/</loc>
		<lastmod>2025-03-08T04:34:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/americas-diabetes-challenge-unveils-common-challenges-affecting-the-type-2-diabetes-community/</loc>
		<lastmod>2025-03-08T04:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-first-quarter-2017-financial-results/</loc>
		<lastmod>2025-03-08T04:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference/</loc>
		<lastmod>2025-03-08T04:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/real-world-observational-study-in-the-u-s-veterans-affairs-system-evaluating-use-of-mercks-zepatier-elbasvir-and-grazoprevir-shows-high-sustained-virologic-response-rates-in-patients/</loc>
		<lastmod>2025-03-08T04:34:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-new-phase-2-data-on-investigational-triple-combination-therapy-mk-3682b-for-chronic-hepatitis-c/</loc>
		<lastmod>2025-03-08T04:34:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-medicines-agencys-chmp-recommends-approval-of-mercks-keytruda-pembrolizumab-for-the-treatment-of-patients-with-relapsed-or-refractory-classical-hodgkin-lymphoma/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/incyte-and-merck-provide-additional-details-on-previously-announced-collaboration-investigating-epacadostat-and-keytruda-pembrolizumab/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-first-quarter-2017-sales-and-earnings-conference-call-on-may-2/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-new-data-on-zepatier-elbasvir-and-grazoprevir-and-investigational-combination-therapy-mk-3682b-for-the-treatment-of-chronic-hepatitis-c-infection-at-the-international-liver-co/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-2017-energy-star-sustained-excellence-award-from-u-s-environmental-protection-agency/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-complete-response-letter-from-the-u-s-fda-for-tecos-study-with-sitagliptin/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/dr-john-h-noseworthy-nominated-to-stand-for-election-to-merck-board-of-directors/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/togo-becomes-first-country-in-africa-to-validate-the-elimination-of-lymphatic-filariasis-as-a-public-health-problem/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-underscores-continued-commitment-to-fighting-infectious-diseases-with-more-than-25-data-presentations-at-eccmid-2017/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-donates-300000-to-support-neglected-tropical-disease-elimination-efforts-in-africa/</loc>
		<lastmod>2025-03-08T04:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-adult-and-pediatric-patients-with-classical-hodgkin-lymphoma-chl-refractory-to-treatment-or-who-have-relapsed-after-three-or-more-pri/</loc>
		<lastmod>2025-03-08T04:34:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-animal-health-completes-acquisition-of-vallee-s-a/</loc>
		<lastmod>2025-03-08T04:34:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/recent-survey-finds-many-adults-with-diabetes-unaware-of-their-increased-risk-for-certain-serious-illnesses/</loc>
		<lastmod>2025-03-08T04:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-second-quarter-2017-dividend/</loc>
		<lastmod>2025-03-08T04:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-pfizer-announce-u-s-fda-and-ema-filing-acceptances-of-three-marketing-applications-for-ertugliflozin-containing-medicines-for-adults-with-type-2-diabetes/</loc>
		<lastmod>2025-03-08T04:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-in-previously-treated-advanced-microsatellite-instability-high-cancer/</loc>
		<lastmod>2025-03-08T04:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-epoch-study-of-verubecestat-for-the-treatment-of-people-with-mild-to-moderate-alzheimers-disease-to-stop-for-lack-of-efficacy/</loc>
		<lastmod>2025-03-08T04:34:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-fight-against-infectious-disease-goes-digital-with-launch-of-ilum-health-solutions/</loc>
		<lastmod>2025-03-08T04:34:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/in-first-phase-3-trial-mercks-investigational-inactivated-varicella-zoster-virus-vaccine-v212-reduced-the-incidence-of-confirmed-herpes-zoster-cases-by-an-estimated-64-percent-in-immunocom/</loc>
		<lastmod>2025-03-08T04:34:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-letermovir-an-investigational-antiviral-medicine-for-prevention-of-cytomegalovirus-cmv-infection-in-bone-marrow-transplant-recipients-highly-effective-through-week-24-post-transpla/</loc>
		<lastmod>2025-03-08T04:34:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-two-sblas-for-mercks-keytruda-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer-in-cisplatin-ineligible-first-line-and-second-line-post-platinum-failure-t/</loc>
		<lastmod>2025-03-08T04:34:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-announces-six-program-grant-recipients-for-alliance-to-advance-patient-centered-cancer-care/</loc>
		<lastmod>2025-03-08T04:34:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-doravirine-an-investigational-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-for-the-treatment-of-hiv-1-infection-met-primary-efficacy-endpoint-in-pivotal-phase-3-trial/</loc>
		<lastmod>2025-03-08T04:34:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-keytruda-pembrolizumab-for-first-line-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-nsclc-whose-tumors-have-high-pd-l1-expression-with-no-egfr/</loc>
		<lastmod>2025-03-08T04:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-fourth-quarter-and-full-year-2016-financial-results/</loc>
		<lastmod>2025-03-08T04:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/msd-for-mothers-commits-10-million-and-business-expertise-to-the-global-financing-facility-to-help-end-preventable-deaths-of-mothers/</loc>
		<lastmod>2025-03-08T04:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-settlement-and-license-agreement-resolving-keytruda-pembrolizumab-patent-litigation/</loc>
		<lastmod>2025-03-08T04:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/pro-football-hall-of-famer-and-cancer-survivor-jim-kelly-teams-up-with-merck-and-leading-cancer-organizations-to-launch-your-cancer-game-plan/</loc>
		<lastmod>2025-03-08T04:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/incyte-and-merck-to-advance-clinical-development-program-investigating-the-combination-of-epacadostat-with-keytruda-pembrolizumab/</loc>
		<lastmod>2025-03-08T04:34:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-fda-acceptance-of-supplemental-biologics-license-application-for-keytruda-pembrolizumab-in-combination-with-chemotherapy-for-first-line-treatment-of-metastatic-non-squamous-non/</loc>
		<lastmod>2025-03-08T04:34:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-grant-expands-project-echo-in-vietnam-and-india/</loc>
		<lastmod>2025-03-08T04:34:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-fourth-quarter-and-full-year-2016-sales-and-earnings-conference-call-on-february-2/</loc>
		<lastmod>2025-03-08T04:34:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-participate-at-the-35th-annual-j-p-morgan-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:34:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-provides-update-on-keytruda-pembrolizumab-supplemental-biologics-license-application-sbla-for-keynote-042-trial/</loc>
		<lastmod>2025-03-08T04:34:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lynparza-olaparib-meets-primary-endpoint-in-phase-3-solo-3-trial-for-the-treatment-of-relapsed-brca-mutated-advanced-ovarian-cancer/</loc>
		<lastmod>2025-03-08T04:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-the-treatment-of-adult-and-pediatric-patients-with-recurrent-locally-advanced-or-metastatic-merkel-cell-carcinoma-a-rare-form-of-skin-c/</loc>
		<lastmod>2025-03-08T04:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/lynparza-olaparib-approved-by-fda-for-first-line-maintenance-therapy-in-brca-mutated-advanced-ovarian-cancer/</loc>
		<lastmod>2025-03-08T04:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-mercks-keytruda-pembrolizumab-as-adjuvant-therapy-for-adults-with-resected-stage-iii-melanoma/</loc>
		<lastmod>2025-03-08T04:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-citi-2018-global-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-mercks-delstrigo-doravirine-lamivudine-tenofovir-disoproxil-fumarate-a-once-daily-fixed-dose-combination-tablet-as-a-complete-regimen-and-pifeltro/</loc>
		<lastmod>2025-03-08T04:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-president-of-global-human-health-adam-h-schechter-to-leave-merck-frank-clyburn-named-chief-commercial-officer-and-michael-nally-named-chief-marketing-officer/</loc>
		<lastmod>2025-03-08T04:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-acquire-privately-held-antelliq-group/</loc>
		<lastmod>2025-03-08T04:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-and-instituto-butantan-announce-collaboration-agreement-to-develop-vaccines-to-protect-against-dengue-infections/</loc>
		<lastmod>2025-03-08T04:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-significantly-improved-overall-survival-os-compared-to-chemotherapy-in-patients-with-advanced-esophageal-or-esophagogastric-junction-carcinoma-whose-tu/</loc>
		<lastmod>2025-03-08T04:34:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-begins-rolling-submission-of-licensure-application-for-v920-rvsv%e2%88%86g-zebov-gp-to-u-s-food-and-drug-administration/</loc>
		<lastmod>2025-03-08T04:34:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-accepts-regulatory-submission-for-lynparza-olaparib-maintenance-therapy-in-newly-diagnosed-brca-mutated-advanced-ovarian-cancer-and-grants-priority-review/</loc>
		<lastmod>2025-03-08T04:34:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-for-the-treatment-of-patients-with-hepatocellular-carcinoma-hcc-who-have-been-previously-treated-with-sorafenib/</loc>
		<lastmod>2025-03-08T04:34:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/new-data-from-investigational-study-of-lenvima-lenvatinib-and-keytruda-pembrolizumab-combination-in-three-different-tumor-types-presented-at-the-society-for-immunotherapy-of-cancer/</loc>
		<lastmod>2025-03-08T04:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/early-phase-1-data-from-mercks-oncology-pipeline-for-investigational-anti-lag-3-therapy-mk-4280-and-anti-tigit-therapy-mk-7684-to-be-presented-at-sitcs-33rd-annual-meeting/</loc>
		<lastmod>2025-03-08T04:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-increased-fourth-quarter-dividend-and-10-billion-share-repurchase-authorization/</loc>
		<lastmod>2025-03-08T04:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-keytruda-pembrolizumab-in-combination-with-carboplatin-and-either-paclitaxel-or-nab-paclitaxel-for-the-first-line-treatment-of-patients-with-metastatic-squamous-no/</loc>
		<lastmod>2025-03-08T04:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-significantly-improved-overall-survival-compared-to-standard-of-care-as-monotherapy-and-in-combination-with-chemotherapy-as-first-line-treatment-for-patients/</loc>
		<lastmod>2025-03-08T04:34:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-third-quarter-2018-financial-results/</loc>
		<lastmod>2025-03-08T04:34:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/solo-1-phase-3-trial-demonstrates-lynparza-olaparib-maintenance-therapy-cut-the-risk-of-disease-progression-or-death-by-70-percent-in-patients-with-newly-diagnosed-advanced-brca-mutated-ovari/</loc>
		<lastmod>2025-03-08T04:34:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-medicines-agency-adopts-positive-opinion-for-mercks-keytruda-pembrolizumab-as-adjuvant-therapy-in-melanoma/</loc>
		<lastmod>2025-03-08T04:34:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-showed-a-complete-response-rate-of-nearly-40-percent-in-patients-with-high-risk-non-muscle-invasive-bladder-cancer-nmibc-unresponsive-to-standard-of-ca/</loc>
		<lastmod>2025-03-08T04:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/first-presentation-of-early-data-for-mercks-investigational-sting-agonist-mk-1454-in-patients-with-advanced-solid-tumors-or-lymphomas-at-esmo-2018-congress/</loc>
		<lastmod>2025-03-08T04:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/u-s-fda-grants-lynparza-olaparib-orphan-drug-designation-for-pancreatic-cancer/</loc>
		<lastmod>2025-03-08T04:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-appointment-of-jim-scholefield-as-chief-information-and-digital-officer/</loc>
		<lastmod>2025-03-08T04:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-keytruda-pembrolizumab-in-combination-with-pfizers-inlyta-axitinib-significantly-improved-overall-survival-os-and-progression-free-survival-pfs-as-first-li/</loc>
		<lastmod>2025-03-08T04:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-week-96-data-from-pivotal-phase-3-drive-ahead-study-evaluating-delstrigo-doravirine-lamivudine-tenofovir-disoproxil-fumarate-for-the-treatment-of-hiv-1-in-treatment-naiv/</loc>
		<lastmod>2025-03-08T04:34:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-hiv-therapy-delstrigo-doravirine-lamivudine-tenofovir-disoproxil-fumarate-meets-primary-efficacy-endpoint-in-phase-3-drive-shift-study-evaluating-switch-to-delstrigo-fro/</loc>
		<lastmod>2025-03-08T04:34:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-acknowledges-the-u-s-department-of-veterans-affairs-va-for-adopting-biosimilar-medicines-to-increase-treatment-options-for-veterans/</loc>
		<lastmod>2025-03-08T04:34:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-broad-oncology-pipeline-to-be-highlighted-at-esmo-2018-congress/</loc>
		<lastmod>2025-03-08T04:34:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-hold-third-quarter-2018-sales-and-earnings-conference-call-on-october-25/</loc>
		<lastmod>2025-03-08T04:34:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-board-rescinds-mandatory-ceo-retirement-policy/</loc>
		<lastmod>2025-03-08T04:34:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-announces-safer-childbirth-cities-initiative-issues-call-to-action-to-reverse-the-rise-in-u-s-maternal-deaths/</loc>
		<lastmod>2025-03-08T04:34:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-grants-priority-review-to-mercks-application-for-keytruda-pembrolizumab-monotherapy-for-first-line-treatment-of-locally-advanced-or-metastatic-non-small-cell-lung-cancer-in-patien/</loc>
		<lastmod>2025-03-08T04:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-publishes-corporate-responsibility-report/</loc>
		<lastmod>2025-03-08T04:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-receives-positive-chmp-opinion-for-delstrigo-doravirine-lamivudine-tenofovir-disoproxil-fumarate-and-pifeltro-doravirine-in-the-european-union-for-the-treatment-of-hiv-1-in/</loc>
		<lastmod>2025-03-08T04:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-commission-approves-mercks-keytruda-pembrolizumab-in-combination-with-pemetrexed-and-platinum-chemotherapy-for-the-first-line-treatment-of-patients-with-metastatic-nonsquamou/</loc>
		<lastmod>2025-03-08T04:34:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-zerbaxa-ceftolozane-and-tazobactam-met-primary-endpoints-of-non-inferiority-compared-to-meropenem-in-pivotal-phase-3-study-of-adult-patients-with-hospital-acquired-bacterial-pn/</loc>
		<lastmod>2025-03-08T04:34:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-for-keytruda-pembrolizumab-for-the-treatment-of-merkel-cell-carcinoma-a-rare-form-of-skin-cancer/</loc>
		<lastmod>2025-03-08T04:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/eisai-and-merck-announce-china-national-medical-products-administration-nmpa-approval-of-lenvima-lenvatinib-for-treatment-of-unresectable-hepatocellular-carcinoma-hcc/</loc>
		<lastmod>2025-03-08T04:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/data-from-mercks-leading-lung-cancer-research-program-with-keytruda-pembrolizumab-to-be-presented-at-iaslc-19th-world-conference-on-lung-cancer/</loc>
		<lastmod>2025-03-08T04:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-to-present-at-the-morgan-stanley-16th-annual-global-healthcare-conference/</loc>
		<lastmod>2025-03-08T04:35:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/eisai-and-merck-announce-european-commission-grants-marketing-authorization-for-lenvima-lenvatinib-as-first-line-treatment-in-adults-with-advanced-or-unresectable-hepatocellular-carcinoma/</loc>
		<lastmod>2025-03-08T04:35:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-mercks-delstrigo-doravirine-lamivudine-tenofovir-disoproxil-fumarate-a-once-daily-fixed-dose-combination-tablet-as-a-complete-regimen-and-pifeltro-dorav/</loc>
		<lastmod>2025-03-08T04:35:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/healthy-interactions-and-merck-announce-launch-of-digital-health-platform-designed-to-enhance-patient-engagement-in-diabetes-management/</loc>
		<lastmod>2025-03-08T04:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/fda-approves-expanded-label-for-mercks-keytruda-pembrolizumab-in-combination-with-pemetrexed-alimta-and-platinum-chemotherapy-for-first-line-treatment-of-patients-with-metasta/</loc>
		<lastmod>2025-03-08T04:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/european-medicines-agency-adopts-positive-opinion-for-keytruda-pembrolizumab-combination-with-pemetrexed-and-platinum-chemotherapy-for-the-first-line-treatment-of-metastatic-nonsquamous-non-sm/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/eisai-and-merck-announce-fda-grants-breakthrough-therapy-designation-for-lenvima-lenvatinib-in-combination-with-keytruda-pembrolizumab-as-therapy-for-previously-treated-patients-with-a/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-and-marshall-health-announce-new-initiative-to-address-opioid-epidemic-in-west-virginia/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/selumetinib-granted-orphan-designation-in-europe-for-neurofibromatosis-type-1/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/mercks-head-of-human-resources-mirian-m-graddick-weir-to-retire-steven-c-mizell-will-assume-role-on-oct-1/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/merck-foundation-supports-new-programs-to-improve-care-for-alzheimers-patients-and-caregivers-in-the-united-states/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.merck.com/news/eisai-and-merck-announce-fda-approval-of-lenvima-lenvatinib-capsules-for-first-line-treatment-of-unresectable-hepatocellular-carcinoma-hcc/</loc>
		<lastmod>2025-03-08T04:35:03+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->